Following fibroblast lineages in dermal development and scars by Ramesh, Pushkar
Comprehensive Pneumology Center / Institute of Lung Biology and Disease 







for the awarding of a Doctor of Philosophy 
(Ph.D.) 

































































First supervisor:   PD Dr. Claudia Staab-Weijnitz 
Second supervisor:  Dr. Yuval Rinkevich 
Dean:   Prof. Dr. med. dent. Reinhard Hickel 















I hereby declare, that the submitted thesis entitled:  
 
 




is my own work. I have only used the sources indicated and have not made unauthorised use of 
services of a third party. Where the work of others has been quoted or reproduced, the source is 
always given. 
I further declare that the submitted thesis or parts thereof have not been presented as part of an 
examination degree to any other university. 
 
Munich, 12/02/2021 Pushkar Ramesh 
                                            



















I hereby declare, that the submitted thesis entitled:  
 
Following fibroblast lineages in dermal development and scars 
 






Munich, 12/02/2021           Pushkar Ramesh  
                                             
Place, date       Signature doctoral candidate 
       






Table of contents 
Affidavit ......................................................................................................................................... 4 
Confirmation of congruency ........................................................................................................ 4 
Table of contents ........................................................................................................................... 5 
List of abbreviations ..................................................................................................................... 6 
List of publications ........................................................................................................................ 7 
Introductory summary ................................................................................................................. 8 
Skin and its architecture .............................................................................................................. 8 
Classical stages and diversity of wound repair ........................................................................... 8 
Dermal fibroblast heterogeneity ................................................................................................ 10 
Visualizing fibroblast migration dynamics in dermal development ......................................... 12 
Visualizing fibroblast migration dynamics in wounding: scar development to molecular 
mechanism ................................................................................................................................. 13 
Thesis summary......................................................................................................................... 16 
References ................................................................................................................................. 17 
Publication I ................................................................................................................................ 21 
Publication II ............................................................................................................................... 42 
Appendix: Publication III and IV ............................................................................................. 68 








List of abbreviations 
PF  Papillary fibroblast 
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DP  Dermal papilla 
DWAT Dermal white adipocyte tissue 
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Skin and its architecture 
Skin is the largest organ of the human body. It is composed of three functionally distinct layers: 
epidermis, dermis and hypodermis. The thickness of these layers vary among species (e.g. mouse 
and human) and anatomical locations. For instance, palms and soles have thick skin compared to 
the rest of the body. The topmost layer, the epidermis, is considered to be a highly regenerative 
layer. Acute injuries limited to epidermis are quickly resolved via migration of keratinocytes. This 
is aided by immediate recruitment of innate immune cells and subsequent activation and 
proliferation of keratinocytes (Pastar et al., 2014). The next layer, the dermis, lies directly beneath 
the epidermis. It is subdivided into an upper papillary dermis and lower reticular dermis. Both 
layers contain functionally distinct resident fibroblasts such as papillary fibroblasts (PF), reticular 
fibroblasts (RF), dermal papilla (DP) and dermal white adipocyte tissue (DWAT). In addition, the 
dermis layer houses appendages and structures such as hair follicles, sweat glands, vascular and 
lymphatic networks (Atit et al., 2018). The innermost layer of the skin is the hypodermis or 
subcutaneous fascia layer. This layer connects the dermis to the skeletal muscles. It comprises 
fibroblasts, fat tissues, macrophages and loosely arranged collagen fibers. Functionally, this layer 
mainly provides mechanical cushioning and thermal insulation of the body (Driskell et al., 2014). 
Taken together, skin homeostasis is achieved by constant interaction between the layers and its 
components. 
Classical stages and diversity of wound repair 
Wound healing is a complex physiological process. It occurs in four distinct overlapping stages: 
inflammation, proliferation or epithelialization, maturation and remodeling (Gurtner et al., 2008). 
The repair process eventually leads to several outcomes ranging from perfect tissue regeneration 
to exuberant fibrotic scars. This diversity is dependent on the a) phylogeny, i.e. the specific taxon 
group in the animal kingdom, b) the stage of development at which injury occurred, the c) 
anatomical site where the injury occurred, and finally the depth of tissue injury (desJardins-Park 
et al., 2019).  
In the context of wound repair among species/class (phylogeny), organisms such as axolotls, 






regenerate tissues either fully or with minimal scar (in a scarless manner). In contrast to these 
regeneration-competent organisms, dermal wound healing in mice and humans focusses on quick 
sealing of breached skin as an external barrier. This is achieved by deposition of a dense plug of 
fibrous extracellular matrix (ECM) devoid of original primary and secondary dermal appendages. 
As an intermediate, mammals such as African spiny mice have shown to functionally regenerate 
the wounds to its original form. The validity of these conserved cellular and molecular mechanisms 
provides cues that govern regeneration mode of wound healing. Induction and revival of these 
molecular mechanisms in regeneration-incompetent organisms such as rat, mice and eventually 
humans plays a significant role in scar free wound healing, and is one of the pinnacle goals of 
regenerative medicine as a field (Blanchoud et al., 2018; Brant et al., 2019; Erickson and Echeverri, 
2018; Maden and Varholick, 2020; Yates et al., 2012).  
Wounds caused at a particular developmental stage/ontogeny predicate the repair outcome (Lo et 
al., 2012). This was first documented close to seven decades ago by Arthur Hess who identified 
an uncanny resemblance between fetal wound healing of guinea pigs compared to the regeneration-
competent “primitive” organisms. He inflicted wounds in young and old fetuses and observed 
complete healing in less than 6 days (Hess, 1954). About 40 years ago, similar observations were 
made on 20-week old human fetuses by Ursula Rowlatt. In her experiments, limb amputations 
caused by amniotic constriction bands were completely devoid of inflammation, granulation 
tissues and necrotic material at amputation sites (Rowlatt, 1979).  In the 1990s, a series of studies 
by Longaker, Lorenz and others have identified that transition from scarless wound healing to 
scarring happens after 24 weeks of gestation in humans and gestational days 16.5 to 18.5 in rats. 
Contrary to the previous thought that sterile, nutrient rich environment enables scarless healing, 
they proved that it is an intrinsic property of the fetal ECM and fibroblasts (Armstrong and 
Ferguson, 1995; Lo et al., 2012; Longaker et al., 1994; Lorenz et al., 1992). 
The third factor influencing scarring is a combination of anatomical location, etiology/depth of the 
injury and demographics of an individual. Contrary to head, neck or back skin, wounds on the oral 
mucosa heal with minimal or no scar (Wong et al., 2009). Studies have shown that heterogeneity 
in wound healing potential is mainly due to the differences in angiogenesis, injury environment 






2018; Politis et al., 2016). Etiological studies using high frequency ultrasound analysis have shown 
that large and deep wounds are more susceptible to scarring. The critical depth for scarring 
develops if the injury spans for greater than 33.1% of total skin thickness (Dunkin et al., 2007). 
This indicates that surface injuries to epidermis, papillary dermis, and even partial reticular dermis 
can repair scarlessly. With demographics, young and darker skinned individuals have higher 
tendency of keloid and hypertrophic scars in response to deep skin injuries.    
In conclusion, the repair process in most adult mammalians or higher vertebrates mainly focusses 
on rapid restoration of wounds as an external barrier. This is often achieved by rapid deposition of 
ECM or in some cases pathological scars such as keloids and hypertrophic scars (Martin, 1997; 
Tripathi et al., 2020). Besides the psychological distress and aesthetic implications, scar 
management and treatments causes a huge financial burden. Despite the increasing number of anti-
scarring treatments, medications in the US alone were estimated to be over $12 billion per year. 
Chronic wounds in combination with diabetes, obesity, burns, surgical incisions and lacerations 
pose a substantial economic, clinical and social threat (Griffin et al., 2020; Jiang et al., 2018) . It 
is therefore essential to understand the biological mechanisms, characterize the dynamics and 
heterogeneity of cells involved in scar formation.   
Dermal fibroblast heterogeneity 
As described in the previous section, wound repair is a cell intrinsic process and independent of 
host microenvironment. Cell fate mapping in mice demonstrate the inherent differences in 
heterogeneity depends on the anatomical location of the body. In particular, fibroblasts in dorsal 
dermis originate from the somatic dermo-myotome, which is of mesoderm germ layer origin. 
Whereas, the fibroblasts in face are derived from neural crest and cephalic mesoderm. In contrast, 
fibroblasts in ventral dermis and limbs originate from lateral plate mesoderm (Atit et al., 2018; 
Griffin et al., 2020; Tran et al., 2010). In order to further characterize and understand the 
heterogeneity of fibroblasts, lineage tracing experiments were performed. Based on anatomical 
locations of such lineages, three studies are described below. (Driskell et al., 2013; Hu et al., 2018; 
Rinkevich et al., 2015) 
Driskell et al described that heterogeneous fibroblast population arise from a multipotent 






ligand (DLK1) and Leucine-rich repeat protein 1 (LRIG1). Upon differentiation after E15-E16, it 
gives rise to varieties of subpopulations that differentially express the above markers to commit to 
either reticular (DLK+) or papillary (LGIG1) fibroblast progenitors, which carry more restricted 
developmental potential. These populations have the capacity to further differentiate into distinct 
dermal lineages during further stages of development (Driskell et al., 2014, 2013; Griffin et al., 
2020).  
Similar observations were made by Longaker, Lorenz and colleagues. They identified 
heterogeneous cell lineages that are primary contributors of scarring at various sites of injury. This 
includes, dorsal dermis (origin: dermo-myotome, somatic mesoderm), oral mucosa (origin: neural 
crest) and ventral dermis (origin: lateral plate mesoderm). In the context of ventral dermis, Hu et 
al., characterized fibroblast populations based on early embryonic expression of paired related 
homeobox 1 gene (Prrx1). Here, they identified that lineage with Prrx1 past embryonic gene 
expression (termed PPFs) is the key contributor for scarring as opposed to the Prrx1 negative 
fibroblasts (termed PNFs). This was inferred based on the chromosomal accessibility based on 
ATAC-seq. To further characterize these populations in the context of scarring, they performed 
genetic ablation studies of the PPF population and reported a diminished ECM deposition at the 
injury site (Griffin et al., 2020; Hu et al., 2018). In the context of dorsal dermis, Rinkevich et al. 
identified functionally distinct lineages using the transgenic mouse line En1Cre marked by 
Engrailed-1: En1 gene expression in early embryonic cells. Using lineage tracing and 
transplantation studies, they identified fibroblasts with En1 past expression (termed EPF) and its 
descendants as the primary contributors of scarring in dorsal skin. In contrast, the fibroblast 
without En1 past expression (termed ENF) do not contribute to fibrotic scars (Atit et al., 2018; 
Griffin et al., 2020; Rinkevich et al., 2015). Analogous to the Engrailed-1 lineage in dorsal dermis, 
Rinkevich and colleagues identified heterogeneous fibroblast lineages in neural crest populations 
in oral mucosa marked by Wnt1 lineage past expressing cells. Using Wnt1Cre transgenic line, 
Rinkevich and colleagues identified WPFs as a principal scar contributing lineage coexisting with 
the WNFs. Upon crossing En1Cre and Wnt1Cre populations with R26mTmG transgenic mice, they 
isolated EPF and WPF populations based on GFP positivity. These cells were then reciprocally 
transplanted in oral and dorsal dermis. Subsequently upon wounding, oral dermis containing EPF 






formation is cell intrinsic and independent of the host environment (desJardins-Park et al., 2018; 
Rinkevich et al., 2015). 
From these studies, it is clear that from a developmental standpoint, there is a vast heterogeneity 
of fibroblast lineages. Albeit the morphological similarities in these lineages, they are functionally 
committed and confined to its respective anatomical locations.  
Visualizing fibroblast migration dynamics in dermal development 
Localized fibroblast lineages in various anatomical sites clearly contribute to the outcome of 
wounds. However, little is known about the role and migration dynamics of these lineages in the 
context of development. This may be due to the technical difficulties in embryo preparation, 
embryo culture, in vivo imaging, computational cell tracking and analysis.  In publication I, we 
have established and employed a combination of recently developed state-of-the-art approaches to 
chart the embryonic EPF and ENF dynamics. These lineages are visualized by crossing En1Cre or 
Wnt1Cre to the R26mTmG (dual color) or R26VT2/Gk3 (four color) transgenic fluorescent reporter 
mouse lines (Jiang et al., 2018; Rinkevich et al., 2015). 
The advancement of fluorescent reporter mouse lines enables us to specifically label the cell / 
tissue of interest. However, until recently, visualization of these labelled tissues was classically 
examined on 2-D cell cultures or on histological slices. Cell localization, migration and trajectory 
studies in a live tissue, organ and organismal context require inspection of samples in along 3-D 
space and time. From a biological stand point, almost all vertebrates and invertebrates contain high 
amount of lipids and pigments. From a microscopy/imaging standpoint these substances lead to 
scattering and impede light penetration, excitation and detection of fluorophores from labelled 
tissues. Recent advancements in “tissue clearing” enable us to clear these lipids and pigments. As 
a result, this renders the tissues fully transparent while preserving the tissue morphology and 
cellular integrity. This can be achieved by applying relevant protocols summarized in Ueda et al., 
2020 (Ueda et al., 2020).  In publication I, we have used organic solvent based “modified 3-
DISCO” clearing method described by Ali Ertürk and colleagues. Albeit the advantages of tissue 
clearing in rendering the tissue transparent, till date, it is important to note that “clearing protocols” 






stages (E11.5 to E16.5) were visualized using “3-DISCO” cleared embryos (Ertürk et al., 2012; 
Jiang et al., 2018; Pan et al., 2016; Ueda et al., 2020).  
To chart the migration dynamics of EPFs in dermal development, we performed 3-D time-lapse 
confocal imaging. Murine dermis at E12.5 embryo contains immature translucent dermis, devoid 
of strong pigments and secondary appendages. To ensure ideal conditions for live imaging, we 
equipped the imaging stage with an incubator system. This enables 3-D time-lapse imaging along 
with adequate ex-ovo culture conditions to detect the EPF cell movements (Jiang et al., 2018). To 
analyze the EPF migration dynamics in these 3-D time-lapse datasets, we performed 3-D cell 
tracking using ImageJ plugin Trackmate (Tinevez et al., 2017). Resulting 3-D coordinates with its 
corresponding time points data were analyzed using a custom built R script (Jiang et al., 2018). 
In conclusion, above mentioned 3-D and 4-D imaging pipelines allows analysis of EPF and ENF 
trajectories at a high spatiotemporal and single-cell resolution. Lineage fate mapping studies 
allows visualization of a) dermal morphogenesis and b) lineage transition from regeneration (ENF 
predominant) to scar (EPF predominant) populations in developing embryos (Jiang et al., 2018). 
Visualizing fibroblast migration dynamics in wounding: scar development to molecular 
mechanism 
The fascia system and its contribution to scar formation in the dermis largely remain unexplored. 
As opposed to superficial wounds, scar formation in mammals is a consequence of large-deep 
wounds. Previously, etiological studies by Dunkin et al. demonstrate that scarring is formed if the 
injury spans for > 33% of total tissue thickness (Dunkin et al., 2007). This corresponds to the 
injuries that spans beyond deep reticular dermis and subcutaneous fascia. Our recent findings in 
publication III suggest that scarring is caused by perturbance of subcutaneous fascia. Dermal 
injuries that extends to the fascia layer leads to quick steering of provisional fascial scar matrix 
that seal large-open wounds (Correa-Gallegos et al., 2019). However, fascial EPF dynamics and 
key molecular players that drive the fascial mobilization remain unknown. 
As a follow-up study in publication II, we aimed to chart fascial EPF migration dynamics and a 
molecular mechanism that drives fascia mobilization (Jiang et al., 2020). To summarize, in this 






a) Developed a relevant ex-situ model that emulates fascial EPF dynamics in the context of scar 
development. 
b) Charted live fascial EPF migration dynamics and entire scar development in dermal explants 
using multiphoton microscopy, single cell tracking, and trajectory analysis.   
c) Screened and identified key adhesion molecules involved in scar development. 
d) Validated the role of promising adhesion molecule in murine in-vivo models and human 
explants using CRISPR-Cas9 mediated knockout and adeno associated viral (AAV) 
approaches.   
Previously explored dermal explant models used to study wound healing were performed in a) 
non-native environment or b) devoid of one or more components of dermis. Further, due to then 
unknown role of fascia in scar formation, application of these models were limited to study 
epidermal wound closure (Abd et al., 2016; Li et al., 2020). In order to visualize the entire scarring 
process, we developed a novel dermal ex-vivo model termed “scar-like tissue in a dish” (termed 
SCAD). SCAD assay was performed by excising 2mm full thickness skin (inclusive of epidermis, 
dermis, and subcutaneous fascia) and cultured in a serum supplemented DMSO media with fascia 
facing upwards. Using our En1Cre combined with previously described fluorescent reporter, we 
visualized the entire scarring process using a multiphoton microscope. These modalities enable 
high tissue penetration of light which are achieved using infrared lasers (wavelength: 800-
1300nm). This allows excitation and detection of deep tissue fluorophores at a single cell 
resolution with minimal light scattering. Further, multiphoton modality offers optimal long term 
imaging due to low phototoxicity and photobleaching. In dermis, this ranges from fascia (top 
imaging plane) up to the reticular or papillary dermis (bottom imaging plane). To emulate ideal 
tissue culture conditions, we equipped imaging stage with a suitable incubator (37°C, 5% CO2). 3-
D time-lapse data indicate that fascial EPFs within 24 hours form multiple small clusters of 4-6 
cell aggregates and start invading the inner circle. By day 3, these aggregates coalesce into 4-5 
distinct EPF swarms. Finally by day 4 and 5, these swarms eventually merge into one or two large 
swarms consisting of hundreds of fibroblasts that migrate collectively and uniformly, to the 
epidermis.  
Collective migrations of EPFs clearly indicate that cell swarming is caused by upregulation of 






molecules, at early and late stage SCADs, we identified that swarms are driven by N-cadherin 
upregulation. We further observed that SCADs devoid of fascia and SCADs isolated from non-
scar forming tissues (e.g. oral mucosa) do not generate cell swarms and lack upregulation of N-
cadherin (Jiang et al., 2020). 
In order to validate the above findings, we generated AAVs expressing CRISPR-N-cadherin-
sgRNA constructs to specifically knockdown N-cadherin junctions. Injection of these viral 
particles to fascia of full body Cas9 expressing (R26Cas9) mice showed significant reduction in scar 
area. We further validated the role of N-cadherin and scarring in human SCAD models generated 
from various anatomical locations. Results showed similar patterns of expression from our murine 
SCAD and in-vivo experiments (Jiang et al., 2020).  
In conclusion, considering our recent findings of the involvement of fascia in scar formation, we 
developed an ex-vivo SCAD model to study the entire process of scar development. Inclusion of 
all the layers of murine dermis (epidermis, reticular and papillary dermis, panniculus carnosus and 
subcutaneous fascia) aided in generation of bona fide murine scars. Using this model in 
combination with novel imaging and image-analysis pipelines, we charted the full spectrum of 
EPF migration and scarring dynamics. Next, we aimed to identify cell-cell junction, N-Cadherin, 
in fascia that orchestrated scarring process in mammals. Using N-Cadherin targeted CRISPR 
knockout in combination with viral delivery approaches, we validated the role of N-Cadherin as a 
primary adhesion molecule involved in fascia mobilization. Finally, we demonstrated the 






Thesis summary  
Fibroblast heterogeneity studies have shown that it vastly influences the outcome of wound repair 
(Griffin et al., 2020; Rinkevich et al., 2015). We aimed to characterize the origins of these 
heterogeneous populations in publication I. Here we have shown that during dermal development 
there is an inherent inversion of fibroblast populations from abundant regenerative fibroblasts 
(ENFs) at early fetal stages of development, to abundant scar-producing fibroblasts (EPFs) during 
perinatal and adult life. Using novel imaging and analysis approaches, we have charted the dermal 
maturation dynamics of EPFs during the transition from scar-less (E12) to scarring stages (E16.5) 
of development. We then followed up on the role of scar-forming fibroblasts in postnatal and adult 
stages. In publication III, we identified the subcutaneous fascia as the main anatomical 
contributor of scars upon deep skin injury. Next, we followed the role of fascial scar producing 
cells, EPFs, and its contribution to scar formation in publication II. Here, we developed a relevant 
ex-vivo model called “scar like tissue in a dish”- termed SCAD. We show that scars on SCADs 
emulate the bona fide in-vivo scar phenotype. Using this model, we visualize and chart live 
migration dynamics of EPFs at all stages of scar development. Further, using antibody screening 
and CRISPR-Cas9 based genetic approaches, we identified that N-Cadherin is the adhesion 
molecular that orchestrates EPF and fascial response to scarring. Finally, to check the clinical 
relevance, we validated our N-cadherin mechanistic findings in human skin biopsies from various 
anatomical locations. These findings provide a range of therapeutic avenues in modulating 
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Skin develops in the fetus when dermal fibroblasts establish a porous, ‘basket-weave’ scaffold, providing the tensile strength and extensibility needed for the structural integrity and for 
protective and sensing functions. Injuries to the skin commonly 
lead to loss of these frameworks and replacement by scar tissues, 
which have greatly limited functions. Scar tissue is rarely observed 
in lower vertebrates, where the normal response to injury is a 
complete regeneration of the original dermal structure. However, 
mammals have evolved to heal with scar tissue and undergo a 
regeneration-to-scar phenotypic transition during fetal life1,2. This 
transition has been documented in the back-skin of all mammalian 
embryos studied to date including humans3–7.
Previous studies into the fetal commencement of scarring have 
focused on a multitude of environmental differences between early 
and late fetal stages, including inflammatory responses to injury, 
expressions of morphogenetic proteins, growth factors and extra-
cellular matrix (ECM) components such as hyaluronic acid8. In the 
early 1990s, the influence of the environment on the commence-
ment of scarring was addressed by performing fetal/adult heter-
ochronic transplantations of back-skin tissues in sheep9. The study 
found that donor back-skin tissues respond to injury (scar/regener-
ate) independent of the host microenvironment or the developmen-
tal stage. Thus, the authors concluded that the determining factor 
(or factors) of the commencement of scarring is probably intrinsic 
to the transplanted back-skin graft, most likely its fibroblasts, the 
tissue’s primary secretors of the ECM9,10.
More recently, we have discovered that functionally diverse lin-
eages of fibroblasts coexist in the mouse back-skin and oral cav-
ity11. Embryonic cells that have expressed engrailed 1 (En1), termed 
En1-lineage-past fibroblasts (EPFs), are the primary contributors to 
scarring in various models of pathological scars. Conversely, En1-
lineage-naive fibroblasts (ENFs) do not participate in scar produc-
tion. By transplanting adult ENFs or EPFs in different anatomical 
locations, we determined that the difference in the capacity of EPFs 
and ENFs to form a scar in vivo is cell intrinsic and permanent11.
Here, we followed the fates of EPF and ENF progenitors. We used 
genetic fate-mapping approaches at single-cell and lineage levels, live 
three-dimensional (3D) confocal imaging of lineage-specific cellular 
migrations and immunolabelling coupled with in silico approaches 
to determine how the dermal structure in the back-skin develops. 
We find that ENFs form the sculptures of the dermal lattice and that 
their cell lineage declines during development, concurrent with a 
surge in EPF numbers that predisposes back-skin to scarring.
Results
ENFs are replaced by EPFs during back-skin development. The 
En1 gene is expressed in a small subset of early embryonic cells and 
switched off permanently later in embryogenesis11. To distinguish 
En1-expressing cells and to follow their fibroblastic descendants in 
the developing back-skin, we used a transgenic mouse system where 
En1 expression drives genetic rearrangements (En1Cre). Crossing 
En1Cre with a reporter mouse system (R26mTmG), generated offspring 
where the genetic rearrangement replaced membrane-bound 
tomato red protein (RFP) expression with membrane-bound green 
fluorescence protein (GFP) expression12 (Fig. 1a). The permanent 
replacement of RFP with GFP in all descendant cells allowed puri-
fication schemes of EPFs and ENFs based on GFP+RFP−Lin− and 
GFP−RFP+Lin−, respectively.
Thus, we performed flow cytometric analysis of EPFs and ENFs 
from the total fibroblast population (Lin−, see Methods) in early fetal 
Two succeeding fibroblastic lineages drive dermal 
development and the transition from regeneration 
to scarring
Dongsheng Jiang1,5, Donovan Correa-Gallegos1,5, Simon Christ1,5, Ania Stefanska1, Juan Liu1,  
Pushkar Ramesh1, Vijayanand Rajendran1, Martina M. De Santis1,2,3, Darcy E. Wagner   1,2,3,4 and  
Yuval Rinkevich   1,4*
During fetal development, mammalian back-skin undergoes a natural transition in response to injury, from scarless regeneration 
to skin scarring. Here, we characterize dermal morphogenesis and follow two distinct embryonic fibroblast lineages, based on 
their history of expression of the engrailed 1 gene. We use single-cell fate-mapping, live three dimensional confocal imaging and 
in silico analysis coupled with immunolabelling to reveal unanticipated structural and regional complexity and dynamics within 
the dermis. We show that dermal development and regeneration are driven by engrailed 1-history-naive fibroblasts, whose 
numbers subsequently decline. Conversely, engrailed 1-history-positive fibroblasts possess scarring abilities at this early stage 
and their expansion later on drives scar emergence. The transition can be reversed, locally, by transplanting engrailed 1-naive 
cells. Thus, fibroblastic lineage replacement couples the decline of regeneration with the emergence of scarring and creates 
potential clinical avenues to reduce scarring.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
NATuRE CELL BioLoGY | VOL 20 | APRIL 2018 | 422–431 | www.nature.com/naturecellbiology422
ArticlesNature Cell Biology
back-skin. Dermal fibroblasts were mostly ENFs early on and their 
numbers declined slowly during subsequent development, followed 
by a steep decline between embryonic day 14.5 (E14.5) and E18.5 
(~90% down to ~20%; Fig. 1b,c). The drop in ENF numbers was pro-
portional to total dermal cells (including haematopoietic, endothe-
lial and lymphatic) and to dermal fibroblasts alone (Lin−), indicating 
a clonal disadvantage to ENFs compared to all other dermal pro-
genitors. Conversely, EPF numbers increased from ~2% of dermal 
cells at E14.5 (EPF/ENF ratio = 1/33) to ~72% at postnatal day 0 (P0) 
(EPF/ENF ratio = 4/1) (Fig. 1b,c) and in proportion to all other der-
mal progenitors (Fig. 1c). We then placed ENF and EPF lineages in 
relation to previously described adult mesenchymal cell populations 
based on the expression of surface markers (Supplementary Fig. 1). 
About 3% of Lin− cells expressed fibro/adipogenic progenitor (FAP) 
markers13–15 (Lin–integrin α 7–Sca1+PDGFRα +) that were enriched 
in EPFs (Supplementary Fig. 1c,f,g), whereas pericyte markers16 
(Lin−CD146+) comprised 5% of total Lin− cells and were enriched 
in ENFs (Supplementary Fig. 1d,f,g). Mesenchymal stem cell mark-
ers17 (Lin−CD29+CD105+) were abundant in both ENFs and EPFs 
(Supplementary Fig. 1e–g). Immunolabelling on En1Cre;R26VT2/GK3  
(see Methods) neonate sections showed that adipocytes (fatty acid-
binding protein 4 (FABP4)) or preadipocytes18 (proten delta homo-
logue 1 (Dlk1) and stem cells antigen 1 (Sca1)) were more abundant 
in EPFs (Supplementary Fig. 2a–c). Similarly, the smooth muscle 
marker α -smooth muscle actin (α -SMA) was enriched in EPFs 
compared to ENFs (Supplementary Fig. 2d). Immunostaining of 
reticular and papillary dermis markers (Dlk1, tenascin-C (TNC) 
and CD26) showed that their expression was not exclusive to either 
lineage (Supplementary Fig. 2b,e,f), indicating that EPFs and ENFs 
do not preferentially allocate to either anatomical location.
To determine whether the decline in ENF numbers is due to pro-
grammed cell death or a decrease in proliferation, we performed 
TdT-mediated dUTP nick end labelling (TUNEL) staining and 
immunolabelling of cleaved caspase 3 (Cas3) and the proliferation 
marker Ki67 on sections of E14.5, E16.5 and E18.5 En1Cre;R26mTmG 
embryos. ENFs underwent significantly more apoptosis than EPFs 
at E14.5 and E16.5 (Fig. 1e,f). Conversely, the number of proliferat-
ing EPFs steadily increased from E14.5 to E18.5, whereas ENF pro-
liferation significantly decreased (Fig. 1d,f). Together, our results 
show that the decay in the ENF population is primarily due to a 
clonal disadvantage.
To study the clonal dynamics of ENF-to-EPF replacements in 
situ at single-cell levels, we used a transgenic ‘Rainbow’ reporter 
system (En1Cre;R26VT2/GK3)19. From the moment of En1 expression, 
individual EPF progenitors were genetically marked with one out 
of three alternate fluorescent colours (yellow fluorescent protein 
(YFP), RFP or cyan fluorescent protein (CFP)), whereas ENFs 
expressed GFP. EPF progenitors were absent in the dermis at E9.5 
and first appeared at E10.5 (Fig. 2a–d). Coronal sections at E10.5 
showed that single EPFs and monoclones developed in close asso-
ciation with the ectoderm and then extend from the most anterior 
regions (neck level) down to half of the trunk (Fig. 2b,c). EPFs 
remained absent in most posterior regions (including hindlimbs) 
at this stage. At E11.5, EPFs formed two parallel mid-lateral lines 
that covered the entire back (Fig. 2e). 3D reconstruction of E12.5 
embryos showed that EPFs arrange themselves in an arc across the 
back-skin, with migration ‘protrusions’ at anterior sites (Fig. 2f and 
Supplementary Video 1).
We next performed immunolabelling of ECM proteins on his-





























































































































































































Fig. 1 | EPFs replace ENFs during mouse back-skin development. a, Genetic-labelling systems used ‘colour-coded’ cells. b, Representative flow cytometry 
plots of ENFs and EPFs from En1Cre;R26mTmG embryos at different developmental stages. All Cre+ embryos (ranging from 3 to 6 embryos) from an entire litter 
were pooled together for a single analysis. GFP intensity (x axis) is plotted against RFP intensity (y axis). c, EPFs and ENFs percentages of Lin–  
(solid lines) or total live cells (dashed lines). d,e, Representative immunofluorescence images of Ki67 (d) or Cas3 (e) in E18.5 En1Cre;R26mTmG embryos; 
arrows indicate Ki67-positive or Cas3-positive cells, respectively. Scale bars, 50 µ m. f, EPFs and ENFs positive for Ki67, Cas3 or TUNEL. n =  optical fields 
analysed from sections of three E14.5 embryos, two E16.5 embryos and one E18.5 embryo stained for Ki67 (n =  24, 28 and 16, respectively), Cas3 (n =  20, 
15 and 14, respectively) and TUNEL (n =  9, 28 and 7, respectively). Mean ±  s.e.m. ANOVA, Tukey test, *P <  0.05, **P <  0.01, ***P <  0.001. Additional 
adjusted P values are listed in Supplementary Table 1.
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Unexpectedly, we found that ENFs deposited fibronectin fibres, but 
not collagen I and collagen III (Fig. 2g), indicating that ENFs gen-
erate a provisional matrix. At anterior sites, collagen I and collagen 
III fibres were visible within the dermal matrix in association with 
EPF clones, indicating that EPFs form a ‘mature’ dermis (Fig. 2h,i). 
Indeed, at later stages, collagen I expression was associated with 
EPFs (Supplementary Fig 3). To view the dynamics of ENF-to-EPF 
replacement, we performed live 3D confocal imaging of the develop-
ing back-skin of En1Cre;R26mTmG embryos (E12.5) at the anterior mar-
gin of the EPF arc (Supplementary Fig. 4). We found that the ENF 
cytological structure is displaced to create open gaps into which EPFs 
migrated (Fig. 2j, Supplementary Fig. 4 and Supplementary Video 2). 
EPFs colonized the provisional dermis, through both dorsal and lat-
eral trajectories (arrows in Fig. 2j). This local dynamic displacement 
of ENF-to-EPF cytological structures was completed within 24 hours.
We then analysed the migration behaviours of single cells in 3D 
by automatically tracking the migration paths of EPFs at 15-min 
intervals. We obtained 144 high-quality tracks of fibroblasts across 
an area of ~170 µ m2 and ~100-µ m deep (Fig. 3a). From a coronal 
plane of view, we observed characteristic reticular patterns in which 
EPFs follow seemingly collective behaviours (Fig. 3b). The EPFs 
migrated in vertical columns along the dorsal–ventral axis (Fig. 3c,d). 
Anterior tracks had more dispersed points along the dorsal–ventral 
axis than posterior tracks, indicating that anterior EPFs migrated 
faster than posterior EPFs (Fig. 3e,f).
Unexpectedly, EPFs migrated ununiformly and in three dis-
tinctive ways: (1) ‘converging’ migration to a fixed space (Fig. 3b), 
(2) ‘localized’ migration where EPFs move in a limited space without 
directly contacting each other (Fig. 3g) or (3) ‘diverging’ migration 
of several EPFs from a space unit (Fig. 3h). These three migration 
types occurred in clusters of 3–6 fibroblasts that shared common 
behaviours. Sequences of several units with varied migration behav-
iours could be detected even along a relative short distance of 170 µ m, 
indicating that EPF movements in situ are directed locally by micro-
environmental cues. These observations are in contrast to observa-
tions from fibroblast migration assays in 2D and demonstrate that 
EPFs exhibit intricate migration repertoires in vivo.
Dermal lattice development follows En1 lineage replacement. 
Having documented the cellular conversion from ENFs to EPFs, 
E9.5a
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Fig. 2 | EPFs direct dermis development. a–e, Coronal sections of E9.5–E11.5 En1Cre;R26VT2/GK3 embryos. Arrows indicate single EPFs (b,d). Dashed line 
indicates the ectoderm (ec) border (b). Dotted lines delimitate EPFs clones (c–e). f, E12.5 En1Cre;R26VT2/GK3 embryo showing that EPFs arc across the back-
skin. f’ and f” indicate high magnification from boxes in f. Arrows indicate migrating EPFs. The cross indicates the embryonic axes. Ant, anterior; D, dorsal; 
Pos, posterior; V, ventral. g–i, Immunofluorescence for fibronectin (g), collagen I (h) or collagen III (i) in coronal sections of E9.5 or E11.5 En1Cre;R26VT2/GK3  
embryos. Dotted lines delimitate EPFs. j, Orthogonal view from time-lapse images (0 h and 24 h) from the anterior region of an E12.5 En1Cre;R26mTmG 
embryo. Dotted lines in the x–y frame delimitate the EPF-induced ENF gap. The green channel (EPFs) was omitted in x–y frames for clarity. Dotted lines 
from x–z and y–z delimitate EPFs. Dashed lines mark the dorsal surface. Arrows indicate the movement direction of EPFs. Scale bars, 50 µ m (a–d), 500 µ m 
(e,f), 200 µ m (f',f'',g–i) and 100 µ m (j). Images in a–j are representative of three experiments.
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we went on to describe dermal lattice development. As the der-
mal structure is too complex to be analysed with simple Euclidean 
geometry parameters, we turned to fractal analysis to measure 
the complexity of cellular and ECM fibre arrangements. In this 
analysis, the fractal dimensions (FD) and lacunarity (L) values 
quantitatively assess the complexity and porosity of 2D shapes 
(Supplementary Fig. 5a). The complex arrangements (for example, 
blood vessels and tumours20–22) score higher FD values than simpler 
arrangements (for example, geometrical shapes). Porous structures 
(for example, sponges) score higher L values than smooth surfaces 
(for example, scales).
We first resolved the cellular organization during dermal mor-
phogenesis using histological sections of En1Cre;R26VT2/GK3 embryos. 
Early (E11.5–E12.5) ENF regions were smoother and more com-
plex, whereas later stages (E14.5–E16.5) became simpler and more 
porous (Supplementary Fig. 5b,c). This indicates a drift from a 
compact mesenchymal arrangement to a more interspaced cellu-

















































































Fig. 3 | EPFs exhibit three migration behaviours in vivo. a, 4D scatter plot of individual tracks; the colour ramp indicates time (blue, first time point; red, 
last time point). b, Top x–y view showing the reticular patterns of migration. Dashed lines in the zoomed view (right panel) delimitate 'converging' track 
points. c,d, Lateral y–z views of posterior (c) or anterior (d) tracks split into dorsal (up) and ventral (down) regions. e,f, Frontal x–z views of posterior (e) or 
anterior (f) tracks. g,h, Amplified view of single tracks showing 'localized' (g) or 'diverging' (h) migrations. Colour ramps of tracks of no interest (g,h) were 
changed to greyscale for clarity. Axes units, µ m. The 144 cell tracks were derived from one representative video.
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Fig. 4 | Dermal lattice is actively changing during development. a,b, Fractal dimension (FD) values (a) and lacunarity (L) values (b) derived from images 
of EPFs from different regions and developmental stages. Mean ±  s.e.m. Repeated measures ANOVA, Newman–Keuls test, n =  9 optical fields of anterior or 
posterior regions at E11.5, E12.5, E14.5 and E16.5. *P <  0.05, **P <  0.01 and ***P <  0.001. c, 3D reconstructions of posterior and anterior En1Cre;R26VT2/GK3  
EPFs. d, Distances (µ m) between fibronectin fibres calculated from linear profiles of three confocal images of fibronectin-immunolabelled sections 
(Supplementary Fig. 6; n =  184 (E11.5 anterior), 138 (E11.5 posterior), 135 (E12.5 anterior), 155 (E12.5 posterior), 98 (E14.5 anterior), 105 (E14.5 posterior), 
91 (E16.5 anterior), 128 (E16.5 posterior) measurements), mean ±  s.e.m., ANOVA, Holm–Sidak test, *P <  0.05. e,f, FD values (e) and L values (f) derived 
from fibronectin stainings from different regions and developmental stages. Mean ±  s.e.m. Repeated measures ANOVA, Newman–Keuls test, n =  3 
optical fields of anterior or posterior regions at E11.5, E12.5, E14.5 and E16.5. *P <  0.05, **P <  0.01 and ***P <  0.001. g, Fibronectin matrix changes from 
a relaxed framework to a rigid matrix. h, FSP1 expression in anterior (left) or posterior (right) regions of E12.5 ActinCre-ER;R26VT2/GK3 embryos after 24 h of 
1 nM 4-hydroxytamoxifen exposure. Dotted lines delimitate single clones. i, Percentage of labelled cells in clones from two independent embryos. j, Local 
(subsampled) fractal analysis of a E16.5 En1Cre;R26VT2/GK3 dermis. Dashed lines delimitate dermal layers. k, Percentages ±  s.e.m. of EPFs and ENFs in each 
layer; n =  3 optical fields. Two-way ANOVA, *P <  0.05, Tukey test. l, Mean ±  s.e.m. number of cells per 1,000 µ m2 of each layer; n =  3 optical fields.  
One-way ANOVA, *P <  0.05, Tukey test. m,n, FD values (m) and L values (n) derived from different dermal layers; n for FD and L, respectively =  58 and 58 
(epidermis), 65 and 65 (DL-1), 198 and 199 (DL-2), 62 and 62 (DL-3), 274 and 281 (DL-4), 92 and 92 (DL-5), and 87 and 91 (hypodermis) subsampled 
values pooled from 3 confocal images. Box and whiskers plots with minimum, lower quartile, median, upper quartile and maximum. One-way ANOVA, 
*P <  0.05, Tukey test. Scale bars, 20 µ m (c), 200 µ m (h) and 50 µ m (j). P values are listed in Supplementary Table 1.
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at E12.5 were more complex and smoother than posterior cells 
(Supplementary Fig. 5c), indicating that, at E12.5, anterior and pos-
terior regions have different cellular organizations.
Conversely, EPFs underwent two major cellular rearrange-
ments during development: (1) early EPFs (E10.5–E11.5) cluster 
tightly in complex patterns, with individual cells having smooth 
shapes; and (2) after E12.5, these clusters split into individual cells 
with increasing complex arrangements (Fig. 4a,b). At E12.5, ante-
rior EPFs decreased in FD value, whereas posterior EPFs retained 
similar complexity to their earlier stage. 3D-rendered pictures of 
single EPFs revealed that posterior EPFs were morphologically 
simpler than anterior EPFs (Fig. 4c). A sudden increase in com-
plexity of anterior EPFs in E12.5 embryos correlated in time with 
the migration of EPFs (Figs. 2f,j and 3, Supplementary Fig. 4 and 
Supplementary Videos 1 and 2), suggesting that changes in EPF 
morphology cause or are caused by migrations. Together, our fractal 
analysis characterizes dynamic spatiotemporal changes in dermal 
lattice development and link dermal maturation steps to distinct 
embryonic fibroblastic lineages.
To determine whether dermal lattice organization is changed fol-
lowing the expansion of EPFs, we analysed matrix fibre alignment at 
different stages in dermal regions that do or do not contain EPFs. As 
collagen precludes the earlier stages of development where EPFs ini-
tially seed the back-skin, we used fibronectin to study the patterns of 
dermal lattice development. The distance between fibres increased 
progressively from E11.5 to E16.5 (Fig. 4d and Supplementary 
Fig. 6), concurrent with EPF development. At the same time, there 










































































Fig. 5 | Regeneration-to-scar transition is coupled to EPFs development. a, E12.5 En1Cre;R26mTmG embryos were collected, wounded on the back-skin and kept 
in culture for 48 h. b,c, Immunofluorescence for fibronectin (b) or collagen I (c). Dotted lines delimitate the lesion site. Arrows indicate EPFs.  
d,e, Representative immunofluorescence images of fibronectin staining at adjacent fetal skin (control) (d) and the wounded site (e) at 48 h post-wounding. 
f, FD values (left) and L values (right) derived from fibronectin staining at adjacent fetal skin (control) and the wounded site at 24 h and 48 h after wounding. 
n =  6 optical fields of control skins and n =  5 optical fields of wounds from two embryos. Mean ±  s.e.m. Two-tailed unpaired Student’s t-test. g, Skin biopsies 
were taken from anterior, middle and posterior regions of E19.5 WT embryos and cultured for 5 days. h, Masson’s trichrome-stained sections of posterior 
or anterior biopsies. Arrows indicate the scar-like deposition of the ECM. i, FD values (left) and L values (right) derived from the cyan channel of Masson’s 
trichrome-stained biopsies. Anterior: n =  11, middle: n =  10 and posterior: n =  9. Mean ±  s.e.m. One-way ANOVA, Tukey test, *P =  0.0436. Scale bars, 200 µ m.
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(Fig. 4e,f). This demonstrates that a gradual transformation of the 
dermal fibronectin matrix occurs, from a relaxed and disorganized 
framework towards a more stretched conformation (Fig. 4g). Our 
fractal analysis of EPF’s cellular arrangements stresses that E12.5 
is a pivotal time-point when anterior regions are actively chang-
ing while posterior regions are still dormant. The co-occurrence 
of fibronectin framework transformation and EPF morphologi-
cal changes links ECM arrangements with distinct cell-migration 
behaviours during development. To directly prove this link, we used 
an inducible-Cre labelling system to follow single fibroblastic cells 
(either ENFs or EPFs) and their sibling cells during back-skin devel-
opment, and compared behaviours between anterior and posterior 
sites. Fibroblastic clone size increased and clone expansion extended 
across the dorsal–ventral axis in the most anterior locations, whereas 
singly labelled cells and small clones remained close to the ectoderm 
in posterior regions (Fig. 4h,i). These experiments show that the 
dynamics of structural changes across the anterior–posterior dermal 
axis influence both the cell division rate of fibroblastic precursors 
and the migration trajectories of their clonal colonies.
Next, we aimed to detect in more detail discrete cellular arrange-
ments at later stages, when fibroblast clones are too widespread and 
intermixed. We generated a tissue-level description of dermal cel-
lular organization by calculating local FD and L values from E16.5 
En1Cre;R26VT2/GK3 embryos. Low-power images showed that more-
compact tissues, such as the epidermis, hypodermis, muscle and 
cartilage, had higher FD values than the dermis (Supplementary 
Fig. 5d,e), indicating the validity of the fractal analysis. From the 
high-power images, we could identify five distinct dermal lay-
ers (DL-1–DL-5) organized in parallel sheets across the back-skin 
(Fig. 4j–n). DL-1 and DL-5 were in direct contact with the epi-
dermis and the hypodermis, respectively, were more complex and 
smoother, and were composed of densely packed EPFs (~85% and 
~75%, respectively). DL-2 and DL-4 were simpler and porous, and 
were composed predominantly of EPFs (~75% and ~90%, respec-
tively). DL-3 was complex and porous and was composed primarily 
of elongated ENFs (~75%). Thus, the cellular organization of the 
dermis at E16.5 has a mirrored pattern with outer flanking dense 
dermal layers that are in direct contact with the epidermis and the 
hypodermis, and two intermediate porous layers, which are sepa-
rated by a middle layer devoid of EPFs. Critically, within each inter-
nal layer there are microdomains with distinct complexity values 
across the anterior–posterior axes. Tissue structure complexity and 
porosity does not vary linearly across these microdomains. In fact, 
in several places, the deep dermis is abruptly interspersed with dis-
tinct cellular arrangements (right panels in Fig. 4j), which might 
result from local migration patterns at earlier stages of development.
Scarring transition follows an anterior-to-posterior sequence. 
We showed above that EPFs increase within the back-skin from an 
anterior-to-posterior sequence. We previously showed that adult 
EPFs produce scars11. Thus, we speculated that the fetal regener-
ation-to-scar transition is linked to engrailed lineage replacement 
and could be due to the gradual increase in EPF abundance during 











































Fig. 6 | EPFs are a mature scar-matrix-depositing population. a, E16.5 or P1 En1Cre;R26mTmG EPFs were sorted and transplanted (2 ×  105) into fresh splinted 
wounds of adult Rag2–/– mice (SCID) and the tissue was collected 14 days later. b–e, Immunofluorescence for collagen I of scars (b,d) or ectopic uninjured 
sites (c,e) containing transplanted EPFs from P1 mice (b,c) or E16.5 embryos (d,e). e’ is a high-magnification image of a collagen I-attached EPF. Dotted 
lines delimitate the cell bodies of EPFs. f, Collagen I FD and L scatter plot of E12.5 and adult normal dermis, adult scars and scars derived from E16.5 EPFs 
transplants. Scale bars, 50 µ m (b–e) and 20 µ m (e'). Images represent one out of three experiments.
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Fig. 7 | ENF and ECM transplantations improve scar outcomes. a, E16.5 En1Cre;R26mTmG EPFs were sorted and transplanted (2 ×  105) into fresh splinted 
wounds of adult Rag2–/– mice and the tissue was collected 2 weeks later. b,c, Masson’s trichrome staining of the EPF-transplanted scar (b) and the  
ENF-transplanted scar (c). d, FD values (left) and L values (right) derived from the cyan channel of Masson’s trichrome-stained sections. Mean ±  s.e.m. 
n =  11 optical fields of control, n =  7 optical fields of EPF transplants and n =  9 optical fields of ENF transplants. One-way ANOVA, *P <  0.05, Tukey test.  
e–g, Representative immunofluorescence images of CD31 staining on mock-transplant scars (control) (e), EPF-transplant scars (f) or ENF-transplant scars 
(g). h,i, Quantification of CD31 integrated fluorescence density (h) and CD31+ cells per low-power (× 20) image (i) of mock-transplant, EPF-transplant 
and ENF-transplant scars. Mean ±  s.e.m. n =  4 optical fields of control, n =  4 optical fields of EPF-transplant scars and n =  9 optical fields of ENF-transplant 
scars, pooled from two independent experiments. One-way ANOVA, *P <  0.05, Tukey test. a.u., arbitrary unit. j, Decellularized matrix transplantation 
experiment. Back-skin explants from P5 WT mice were decellularized and transplanted into fresh splinted wounds of adult Rag2–/– mice and the tissue was 
collected 10 days later. k–m, Masson’s trichrome-stained (k–m) or α -SMA-stained and collagen I-stained (n–p) control wounds (k,n), the border between 
the transplanted matrix and the wound (l,o) or within the transplanted matrix (m,p). Scale bars, 50 µ m. Images in panels b,c, e–g and k–p represent one 
out of two experiments. The exact P values are listed in Supplementary Table 1.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
NATuRE CELL BioLoGY | VOL 20 | APRIL 2018 | 422–431 | www.nature.com/naturecellbiology 429
Articles Nature Cell Biology
inflicted at early fetal stages would regenerate from ENFs and that 
the transition from regeneration-to-scarring would take on an ante-
rior-to-posterior sequence.
To test our first hypothesis, we generated wounds in the back-
skin of En1Cre;R26mTmG E12.5 embryos and analysed both lineage 
compositions and ECM depositions (Fig. 5a). At 48 hours post-
wounding, ENFs had migrated into wound beds, where a provi-
sional fibronectin-rich matrix had been generated, virtually absent 
of EPFs or collagen I fibres (Fig. 5b,c). Fractal analysis of fetal 
wounds indicated that lattice arrangement at the injury site was 
not different from that of the adjacent fetal skin (Fig. 5d–f). Thus, 
during fetal skin regeneration, ENFs sculpt the wound-bed matrix 
without the intervention of EPFs.
To test our second hypothesis, we cultured skin biopsies from dif-
ferent anterior–posterior regions of E19.5 wild-type (WT) embryos 
(Fig. 5g). Anterior biopsies deposited significantly more collagen-
rich scars (right panel in Fig. 5h) than posterior biopsies (left panel 
in Fig. 5h). Fractal analysis revealed that the posterior matrix was 
significantly simpler than the anterior matrix (Fig. 5i), suggesting 
that, at this stage, anterior fibroblasts are more fitted to create a scar 
than are posterior fibroblasts. Collectively, these experiments dem-
onstrate that the fetal regeneration-to-scar transition follows the 
increase in EPF abundance during dermal development.
En1 lineage replacement drives regeneration-to-scar transition. We 
next asked whether EPFs from early stages possess scarring capacities 
or whether, alternatively, they undergo a developmental maturation, 
whereby they acquire scar-producing abilities over time. To test this 
idea, we purified EPFs from the back-skin of En1Cre;R26mTmG embryos/
neonates at regenerating (E16.5) or scarring (P1) stages and intrader-
mally transplanted them in equal number (2 × 105) around the edges 
of fresh splinted wounds on the back-skin of adult immunodeficient 
(Rag2–/–) mice. We then assessed the contribution of EPFs from dif-
ferent ages to scar formation 14 days after transplantation/wounding 
(Fig. 6a). Transplanted EPFs from P1 that migrated into the wounds 
deposited collagen I extensively within host wound beds (Fig. 6b). 
Some EPFs deposited ectopic collagen I at their original transplanted 
location (Fig. 6c). Strikingly, transplanted EPFs from E16.5 embryos 
had the same scarring capacities as P1 EPFs, depositing collagen I 
both within wounds and at ectopic uninjured sites (Fig. 6d,e). EPFs 
from both E16.5 and P1 had pathologically active cell morphologies, 
with membrane protrusions that span across and intermingle with 
the collagen I fibres (Fig. 6e). Fractal analysis showed that collagen I 
arrangements were more complex and smoother in EPF-transplanted 
regions (day 14 post-wounding) and in adult scars (day 21 post-
wounding) than in non-injured adult and fetal dermis, which were 
simpler and more porous (Fig. 6f). Our results demonstrate that fetal 
EPFs are capable of producing and organizing a scar tissue, just as 
well as newborn EPFs, and that the absence of scar formation in early 
fetal skin is due to scarcity of EPFs, rather than their developmental 
immaturity. Together, the mechanism behind the dynamic transition 
from regeneration to scarring in fetus is En1 lineage replacement 
during back-skin development.
ENFs or native lattice reduce scarring in adult wounds. As we 
found that ENF abundance in the dermis was associated with 
regenerative outcomes at early stages and as we also showed that 
ENFs sculpted a provisional lattice during development, we asked 
whether transplantation of ENFs alone would regenerate adult 
dermal wounds. To test this hypothesis, we transplanted fetal 
(E16.5) ENFs into back-skin wounds of adult Rag2–/– mice and 
allowed wounds to heal for 14 days (Fig. 7a). As expected, sites 
of ENF transplantations had a more reticular lattice arrangement 
than fibrotic lattice arrangements at sites of EPF transplantations 
(Fig. 7b,c). Fractal analysis indicated that ENF transplantation sites 
were significantly simpler and more porous in lattice arrangements 
than EPF-transplanted sites or mock-transplanted control wounds 
(Fig. 7d). In line with the reduction of scarring severity, immunola-
belling of an endothelial marker, CD31, showed a significantly higher 
infiltration of blood vessels into the wound beds at sites of ENF trans-
plantations than EPF-transplanted or mock-transplanted wounds 
(Fig. 7e–i). Many of the transplanted ENFs were closely associated 
with blood vessels, which were interlaced with one another to gen-
erate vascular networks within the transplanted sites (Fig. 7g).
To test whether the ENF-generated lattice itself promotes a 
regenerative outcome, we transplanted decellularized back-skin 
from P5 WT mice into back-skin wounds of Rag2–/– mice (Fig. 7j). 
Ten days later, we found that fibroblasts in the control wounds and 
in the borders between the wound and the transplanted matrix 
had a typical active morphology with membrane protrusions 
(Fig. 7k,l). Conversely, resident cells within the transplanted matrix 
had an inactive morphology with round cytoplasm (Fig. 7m). 
Immunolabelling of α -SMA revealed that the activated fibroblasts 
were present in the control wound beds and in the matrix–wound 
border (Fig. 7n,o) and were mostly devoid from transplanted matrix 
(Fig. 7p). These experiments show that a ‘healthy’ dermal lattice can 
be imposed locally in two ways. First, transplanting ENFs expands 
the existing pool of resident ENFs and allows ENFs to sculpt a pro-
visional matrix. Alternatively, transplantations of decellularized 
dermal lattice, in essence, mimic dermal development, and in the 
presence of which EPFs do not promote a pathological scar. Both 
approaches, if they could be made industrially, provide therapeutic 
possibilities for a range of dermal pathologies, including patients 
with large skin burns or wounds.
Discussion
We have previously shown11 that EPFs are the primary cells respon-
sible for fibrotic outcomes in adult settings of wound healing, irra-
diation fibrosis and melanoma cancer growth. Here, we find that 
ENFs, not EPFs, are the primary sculptors that drive dermal lat-
tice development and its regeneration in fetal wound-healing set-
tings. We show that transplanted fetal ENFs and EPFs into adult 
wounds impose regenerative versus scarring outcomes, respectively, 
and that the phenotypic shift in dermal response to injury (from 
regeneration to scarring) is driven by En1 lineage replacement 
(Supplementary Fig. 7).
Using in vivo live imaging, we disclose three distinct migration 
patterns of dermal fibroblasts during back-skin development: local-
ized, diverging or converging migrations. To our knowledge, these 
migration patterns have never been described in 2D or 3D assays 
to date. We hypothesize that each of the three migration patterns 
establishes distinct dermal architectures that collectively drive the 
remarkable architectural complexity that we observe during dermal 
development. Diverging migration patterns could indicate fibro-
blastic cell invasiveness, whereas converging migrations indicate 
collective and interconnected behaviours as opposed to individual-
istic. As fibroblastic migrations impinge on collagen-bundle align-
ments, we expect these individual migration patterns, through their 
distinct molecular programmes, to influence scar tissue severity, as 
well as fibroblastic invasiveness into tumours.
Our findings have additional developmental, evolutionary and 
clinical implications outlined below.
Other groups have recently implicated separate fibroblastic lin-
eages in the differentiation of the back-skin epidermis18,23,24. Fetal 
processes of epidermal development, hair follicle and sebaceous 
gland differentiation may require specialized stromal signals and 
cells. The priority for adults is a quick fix of breached skin, which 
probably requires different stromal signals and cells to produce a 
scar. These two diverged requirements at different stages of fetal life 
are maintained through dynamic cellular shuffling of fibroblastic 
populations, allowing specialized types of fibroblasts to accommo-
date specific fetal and adult requirements.
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We demonstrate here that the ENF-to-EPF switch in the dermis 
imposes the phenotypic transition from regeneration to scarring 
in response to injury. In evolutionary terms, this switch provides 
a model to explain how dermal regeneration was retained in some 
adult rodent species such as African spiny mice25. We speculate that 
such species have retained the fibroblastic cell compositions of fetal-
stage dermis (ENFs > EPFs), and have resisted the ENF-to-EPF lin-
eage successions.
Here, we describe, and map in detail, a mechanism for the gen-
eral acquisition of scarring ability in the skin. We believe both the 
temporal and the spatial dynamics of EPFs, the determinants of 
scarring, will be widely clinically applicable. Consideration of lin-
eages with engrailed history will outline a favourable time window 
for surgeons to work in, when scarring outcomes will be predicted 
to be at a bare minimum, such as during corrective surgery for spina 
bifida, or equally, it could be applicable to the removal of paediatric 
malignancies.
Our findings also carry implications for adult scarring. There 
are no definitive strategies to prevent scar formation, and current 
clinical practice is focused on scar acceptance rather than its ame-
lioration. We have demonstrated two separate strategies that reduce 
scar outcomes in adult injured skin. Both ENF transplantation and 
decellularized dermis transplantation assays provide a proof of 
concept for a therapeutic option that could be used to treat large 
wounds, scolds or burns.
Our findings also create opportunities for the intense field of 
bioengineered autologous dermoepidermal human skin grafts that 
are currently being tested in phase I and phase II clinical studies. 
Skin grafts include all fibroblastic lineages within the dermis and are 
therefore likely to produce scars upon transplantation. We predict 
it would be advantageous to graft pure human ENFs or ENFs com-
bined with dermoepidermal skin. In essence, this dermal milieu 
would override the ENF-to-EPF population shift and favour regen-
eration over scarring.
In summary, we used single-cell clonal analysis, 3D imaging, 
computational cell tracking and in silico analysis to follow the 
behaviours of fibroblast lineages in vivo. We document fibroblast-
lineage-specific proliferations, migrations and secretions, and dem-
onstrate how such a fundamental process as dermal morphogenesis 
actually occurs. Our finding of En1 lineage replacement links der-
mal morphogenesis with the phenotypic shift in response to dermal 
injury. We believe our findings open up previously unrecognized 
opportunities for clinical approaches to ameliorate scar tissues in 
injured adult skin.
Methods
Methods, including statements of data availability and any asso-
ciated accession codes and references, are available at https://doi.
org/10.1038/s41556-018-0073-8.
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Methods
Mice strains and genotyping. All mouse strains (C57BL/6J (WT), En1Cre,  
ActinCre-ER, R26VT2/GK3, R26mTmG and Rag2–/–) were either obtained from Jackson 
laboratories, Charles River, or generated at the Stanford University Research 
Animal Facility as described previously11, and were housed at the Helmholtz 
Center Animal Facility. The rooms were maintained at constant temperature and 
humidity with a 12-h light cycle. Animals were allowed food and water ad libitum. 
All animal experiments were reviewed and approved by the Government of Upper 
Bavaria and registered under the project 55.2-1-54-2532-61-2016 and conducted 
under strict governmental and international guidelines. This study is compliant 
with all relevant ethical regulations regarding animal research.
Cre-positive (Cre+) embryos were identified by detection of relevant 
fluorescence into the dorsal dermis. Genotyping was performed to distinguish 
mouse lines containing 200-base pair (bp) Cre fragment (Cre+/–) from the WT 
(Cre–/–). The genomic DNA from the ear clips was extracted using QuickExtract 
DNA extraction solution (Epicenter) following the manufacturer's guidelines. DNA 
extract (1 µ l) was added to each 24 µ l PCR. The reaction mixture was set up using 
Taq PCR core kit (Qiagen) containing 1× coral buffer, 10 mM dNTPs, 0.625 units 
Taq polymerase, 0.5 µ M forward primer “Cre_genotype_4F”-5′ ATT GCT GTC 
ACT TGG TCG TGG C-3′ ” (Sigma) and 0.5 µ M reverse primer  
“Cre_genotype_4R”-5′ GGA AAA TGC TTC TGT CCG TTT GC-3′ (Sigma). 
PCRs were performed with initial denaturation for 10 min at 94 °C, amplification 
for 30 cycles (denaturation for 30 s at 94 °C, hybridization for 30 s at 56 °C, and 
elongation for 30 s at 72 °C) and final elongation for 8 min at 72 °C, and then cooled 
to 4 °C. In every experiment, negative controls (non-template and extraction) and 
positive controls were included. The reactions were carried out in an Eppendorf 
master cycler. Reactions were analysed by gel electrophoresis.
Cell harvesting and sorting. Dorsal skin of En1Cre;R26mTmG embryos, neonates 
or adult mice were harvested and washed with Hank's balanced salt solution 
(HBSS). Skin was minced into small pieces with surgical scissors and washed again 
with HBSS. The cells was resuspended in 2 ml of digestion solution containing 
1 mg ml–1 of collagenase I, 0.5 mg ml–1 of hyaluronidase and 25 U ml–1 of DNase 
I, and incubated in a 37 °C water bath for 30 min with agitation. DMEM (10 ml) 
containing 10% FBS was added to stop the enzymatic reaction, and the suspension 
was filtered through a 100-µ m and then 40-µ m cell strainer. After centrifugation 
at 300g for 5 min, the cell pellet was resuspended in 1 ml of FACS buffer (0.5% FBS 
in PBS) and incubated with 1 µ g of allophycocyanin (APC)-conjugated anti-mouse 
CD31 (PECAM-1), CD45, Ter119, Tie2 (CD202b) or EpCam (CD326) antibodies 
(BioLegend) and eFluor660-conjugated anti-mouse Lyve-1 antibody (Thermo 
Fisher) on ice for 30 min. A small aliquot of cells was incubated with the respective 
APC-conjugated isotype controls (BioLegend). After washing with 5 ml FACS 
buffer, the cell pellet were resuspended in 2 ml FACS buffer containing 1 µ l of Sytox 
blue (Thermo Fisher). The cells were sorted on a BD FACSAria III cell sorter with 
a 100-µ m nozzle. The viable (Sytox blue–), lineage-negative cells (Lin–: CD31–, 
CD45–, Ter119–, Tie2–, EpCam–, Lyve-1–) were sorted into ENFs (Lin–RFP+GFP−) 
and EPFs (Lin−RFP−GFP+) based on RFP and GFP fluorescence.
The following cell surface antibodies were used in the flow cytometric analysis: 
anti-mouse CD105-PE-Vio770 (Miltenyi), CD146-PerCP-Vio700 (Miltenyi), 
CD140a (pdgfra)-PE-Vio770 (Miltenyi), integrin α 7-APC (Miltenyi); and anti-
mouse Sca1-PerCP-Cy5.5 (eBioscience), CD29-PerCP-eFluor710 (eBioscience).
Splinted wounds on adult mice. Splinting rings were prepared from a 0.5-mm 
silicone sheet (CWS-S-0.5, Grace Bio-Labs) by cutting rings with an outer diameter 
of 12 mm and an inner diameter of 6 mm. After washing with detergent and rinsing 
with water, the splints were sterilized with 70% ethanol for 30 min and air dried in 
a cell culture hood and kept in a sterile bottle.
Mice were anaesthetized with 100 µ l MMF (medetomidine, midazolam and 
fentanyl). Dorsal hair was removed by a hair clipper (Aesculap Schermaschine 
Exacta), followed by hair removal cream for 3–5 min. Two full-thickness excisional 
wounds were created with a 5-mm diameter biopsy punch (Stiefel). One side of a 
splint was applied with silicone elastomer super glue (Kwik-Sil Adhesive, World 
Precision Instruments) and placed around the wound. The splint was secured with 
5 sutures of 6.0 nylon, and the wound was covered with Tegaderm transparent 
dressing (3 M). Mice were recovered from anaesthesia with an MMF antagonist 
and were supplied with metamizol (500 mg metamizol/ 250 ml drinking water) as 
postoperative analgesia.
Cell transplants. Sorted cells were washed with PBS and resuspended in PBS at 
4 × 106 cells per ml and mixed with an equal volume of ice-cold Matrigel (growth 
factor reduced, phenol red free) (356231, Corning) to obtain EPF and ENF 
suspensions in Matrigel at a final concentration of 2 × 106 cells per ml, and stored 
on ice until injection for transplantation. The Rag2–/– mice at 10–12 weeks of age 
were used as recipients of transplanted EPFs and ENFs. Two 5-mm diameter 
full-thickness excisional wounds were created on the back-skin of SCID mice 
as described above. Then, two injections of 50 µ l of prepared EPF–Matrigel or 
ENF–Matrigel solution at a concentration of 2 × 106 cells per ml were made 
intradermally around each wound, which resulted in intradermal transplantation 
of 2 × 105 EPFs or ENFs to each wound. Control wounds received two intradermal 
injections of 50 µ l PBS. Fifteen minutes after injection, the silicone splints were 
applied and fixed around the wounds as described above. Scar tissues were 
harvested 14 days post-wounding and fixed with 2% paraformaldehyde at 4 °C 
overnight. After washing three times with PBS, the tissues were processed for 
histology as described below.
Transplantation of decellularized skin. The dorsal skin of C57BL/6J mice  
(age P5) were subjected to decellularization as described previously26. Briefly, the 
skin tissue was incubated sequentially with: (1) distilled water containing 0.1% 
Triton X-100 and 5× penicillin/streptomycin at 4 °C for 24 h with stirring, then (2) 
distilled water containing 2% sodium deoxycholate at 4 °C for 24 h with stirring, 
(3) distilled water containing 1 M NaCl, 5× penicillin/streptomycin at room 
temperature for 1 h, and finally, (4) distilled water containing 30 µ g ml–1 porcine 
pancreatic DNase, 1.3 mM MgSO4, 2 mM CaCl2 and 5× penicillin/streptomycin at 
room temperature for 1 h. The decellularized skin was stored in PBS at 4 °C until 
transplantation. Two 5-mm diameter full-thickness excisional wounds were created 
on the dorsal back of each recipient Rag2–/– mouse. A 5-mm diameter biopsy of 
decellularized donor skin was transplanted to the recipient’s wound with silicone 
elastomer super glue (Kwik-Sil Adhesive, World Precision Instruments). Wounds 
without a transplant served as control. Subsequently, the wounds were covered 
with a 12-mm diameter silicone sheet (Grace Bio-Labs), fixed with 5 sutures, and 
transparent dressing was applied (3 M Tegaderm Film). The scar tissues were 
harvested 10 days post-wounding and processed for histology.
Ex vivo wounding. E12.5 embryos were harvested from En1Cre;R26mTmG breeding. 
Cre+ embryos were selected based on GFP positivity by observing them under a 
fluorescence stereomicroscope (Leica M205 FA). Small excisional wounds were 
created on the dorsal back of embryos by using fine microsurgical scissors (Vannas 
Spring Scissors, Fine Science Tools) under the stereomicroscope (Leica M50). 
The embryos were kept in Knockout DMEM (Thermo Fisher) supplemented with 
10% KnockOut Serum Replacement (Thermo Fisher), 1% penicillin/streptavidin 
(Thermo Fisher), 1% GlutaMAX (Thermo Fisher) and 1% Non-Essential Amino 
Acids solution (Thermo Fisher) in a 37 °C, 5% CO2 incubator. Embryos were fixed 
with 2% paraformaldehyde at 12 h, 24 h and 48 h after culture and processed  
for histology.
Ex vivo tamoxifen treatment. E12.5 embryos were harvested from  
ActinCre-ER;R26VT2/GK3 breeding. The embryos were kept in Knockout DMEM 
supplemented with 10% KnockOut Serum Replacement, 1% penicillin/
streptavidin, 1% GlutaMAX, 1% Non-Essential Amino Acids solution and 1 nM 
4-hydroxytamoxifen (Sigma-Aldrich) in a 37 °C, 5% CO2 incubator. Twenty-four 
hours later, embryos were fixed overnight with 2% paraformaldehyde at 4 °C and 
processed for histology.
Histology. Tissue samples were fixed overnight with 2% paraformaldehyde in PBS 
at 4 °C. Samples were rinsed three times with PBS, embedded in optimal cutting 
temperature (OCT) compound (Sakura Finetek) and flash-frozen on dry ice.  
Six μ m sections were made in a Hyrax C50 Zeiss Cryostat.
Masson’s trichrome staining was performed with a Sigma-Aldrich Trichrome 
stain kit, according to the manufacturer's instructions.
For immunostainings, sections were air dried for 5 min followed by fixation 
with − 20 °C-chilled Acetone for 20 min. Sections were rinsed three times with 
PBS and blocked for 1 h at room temperature in PBS plus 5% serum. Then, the 
sections were incubated with the primary antibody in PBS serum overnight at 4 °C 
or for 90 min at room temperature. Sections were then rinsed three times with 
PBS and incubated with the secondary antibody in PBS serum for 60 min at room 
temperature. Finally, sections were rinsed three times in PBS and mounted with 
fluorescent mounting media with 4,6-diamidino-2-phenylindole (DAPI).
TUNEL (Life technologies) staining was performed prior to immunolabelling 
according to the manufacturer’s recommendations but avoiding proteinase K 
treatment.
Antibodies used: Ki67 (Abcam), Cas3 (Cell Signaling), collagen I (Rockland), 
fibronectin (Abcam), FSP1 (Abcam), collagen III (Abcam), collagen VI (Abcam), 
CD31 (Novus Biologicals), α -SMA (Abcam), CD26 (Abcam), TNC (Abcam), 
Dlk1 (Abcam), Sca1 (Biolegend), FABP4 (Abcam) and AF647 secondary antibody 
(Molecular Probes).
Live imaging. Pregnant mice were killed 12.5 d.p.c. (days post-coitum) by cervical 
dislocation and uteri were excised. Embryos were dissected in ice-cold medium 
and tested for Cre+ fluorescence. Excised Cre+ embryos were incubated with  
SiR-DNA (Spirochrome) for 1 h (at 37° with 5% CO2). The embryos were 
embedded in 35-mm glass bottom dishes (Ibidi) and Matrigel (Corning) and the 
gel was allowed to solidify for 30 min. Imaging medium (DMEM/F-12; SiR-DNA 
1:1,000) was then added. Twenty-four-hour time-lapse imaging was performed 
using a Zeiss LSM 710, equipped with 488-nm, 515-nm and 633-nm laser lines and 
a × 20 objective. Temperature control was set to 37 °C with 5% CO2-supplemented 
air. Three channels (GFP, tdTomato and AF647) were recorded every 15 min as 
a z-stack of 188-µ m thickness. The 4D data were processed with Imaris 9.1.0 
(Bitplane) and ImageJ. Contrast and brightness were adjusted for better visibility.
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Cell tracking. 3D drift correction was applied on the live-imaging 4D data using 
the ImageJ’s Correct 3D Drift’ in reference to the EPF channel. The resultant drift-
corrected data sets were subjected to maximum intensity projection and visualized 
to verify compensation of the apparent drift in reference to the imaging plane. The 
corrected data sets were subjected to cell migration and cell-tracking analysis using 
‘Trackmate’. Variables, such as blob diameter, threshold, detector (Laplacian of 
Gaussian (LoG) segmentation) and the LAP (linear assignment problem) tracker, 
were adjusted to suit the nature of the data and the samples as described in the 
plugin workflow27. Filters, such as spots with good quality, mean intensity and 
uniform colour, were applied and tracked using the LAP Tracker. Individual track 
information and the coordinates of these data points were exported as an Excel file. 
Graphical representation and visualization of 4D data sets were performed using a 
R script in the 'scatterplot3D' package to represent the tracks on a 3D plane. For the 
fourth dimension of the tracks, colour ramp was applied to the individual tracks as a 
function of time (blue, first time point; red, last time point of the track). To visualize 
the data points on a 3D interactive space (360° rotation and zoom function), the R 
package 'rgl: 3D visualization using openGL' was integrated into the script.
3D imaging. Samples were fixed in 2% paraformaldehyde at 4 °C overnight and 
imaged in a 35-mm glass-bottom dish (Ibidi).
Cleared samples were processed using a modified 3Disco protocol. In short, 
samples were stained with anti-GFP (Abcam) and anti-RFP (SICGEN) for 4 days, 
followed by incubation with AF488 and AF647 secondary antibodies (Molecular 
Probes) for 2 days. Clearing was performed after dehydration in an ascending 
tetrahydrofuran (Sigma) series, with 30-min incubation in dichloromethane 
(Sigma) and eventually with immersion in dibenzyl ether (Sigma). Imaging was 
performed in dibenzyl ether with an inverted confocal (LSM 710, Zeiss) using a 
× 10 or × 20 objectives. Stacks were recorded in the green and far-red channels. 
3D visualization and recording of movies were performed using Imaris 9.1.0 
(Bitplane).
Image analysis. Single × 10 or × 63 images were taken of the EPF-containing 
anterior and posterior fields, in the same section, using a confocal LSM 710 (Zeiss).
Image processing and analysis were performed with ImageJ (ImageJ 1.47  
(ref. 28)). For separating EPF and ENF fluorescent signals, only the red population 
of EPFs was analysed from sections from ‘Rainbow’ mouse, as it provided the 
strongest signal. Channels from the raw images were split, the background was 
subtracted (rolling ball radius = 50 pixels) and contrast was enhanced (pixel 
saturation = 0.1, normalized). The ‘unsharp mask’ and ‘median’ filters were 
applied (radius = 10, mask = 0.60; and radius = 1, respectively). The auto-threshold 
method ‘Yen’ was used to make binary images except for the immunostaining 
signal of fibronectin and collagen I, for which ‘default’ method was used. To 
avoid the inclusion of background signal into the analysis, the pixels from the 
ENF signal were subtracted from the EPF signal and vice versa using the image 
calculator function. For segmentation of the blue colour from trichrome stains, 
× 10 bright-field images were taken with a vertical Axio scope (Zeiss). Images 
were transformed into CMYK and only the cyan channel was used for further 
separation, the background was subtracted (rolling ball radius = 20 pixels) 
and contrast was enhanced (pixel saturation = 0.1, normalized). The ‘unsharp 
mask’ and ‘median’ filters were applied (radius = 2, mask = 0.60; and radius = 1, 
respectively). The auto-threshold method ‘Moments’ was used to make binary 
images, and the ‘despeckle’ function was used to avoid the inclusion of the 
background signal into the analysis.
Fractal analysis was performed using the ImageJ plug in ‘FracLac’29 (FracLac 
2015Sep090313a9390). FD values were calculated using the box counting scan 
(20 slipping and tighten grids at default sampling sizes, minimum pixel density 
threshold = 0.40). L values was calculated using the sliding box scan (slipping and 
tighten grid at default sampling sizes, minimum pixel density threshold = 0.40). 
Local FD and L values were calculated using the subsample scan (1 grid at default 
sampling size, minimum pixel density threshold = 0.40, subscan in rectangles). 
Individual values within the discernible distinct dermal layers were manually 
pooled.
For the collagen I intensity analysis, sections of En1Cre;R26VT2/GK3 embryos at 
different stages were immunostained for collagen I. × 63 images were segmented as 
before. Segmented EPF and ENF binary images were further processed (Options: 
Process_Binary_Fill Holes, and Process_Binary_Close) and a region of interest 
selection was created to measure the mean grey values from the raw images. The 
mean grey values from the region of interest were normalized with the general 
mean grey values of the image. Three images from every condition were analysed.
For the fibronectin fibre distance measurements, sections of En1Cre;R26VT2/GK3  
embryos at different stages were immunostained for fibronectin. × 63 images 
were segmented as before. We used the plot profile function in diagonal lines of 
fibronectin segmented images, and the distance between the fibres was calculated 
as the gaps between the signal peaks. Three images from every condition were 
analysed.
Statistics and reproducibility. Statistical analyses were performed using GraphPad 
Prism software (version 6.0, GraphPad). Statistical significance was determined 
using Student’s t-test or analysis of variance (ANOVA) with Tukey, Holm–Sidak or 
Newman–Keuls multiple comparison test, as indicated in the corresponding figure 
legends. All experiments presented in the manuscript were repeated in at least 
three independent experiments/biological replicates with similar results, unless 
indicated otherwise in the figure legend. Cell-tracking data shown in Fig. 3 were 
derived from 144 high-quality tracks of one representative video. Fig. 7 was derived 
from two independent transplantation experiments of mock control, EPFs, ENFs 
and decellularized skin.
Reporting Summary. Further information on experimental design is available in 
the Nature Research Reporting Summary linked to this article.
Data availability. Source data for Figs. 1,4,5 and 7 and Supplementary Figs. 3  
and 5 have been provided as Supplementary Table 1. All other data supporting the 
findings of this study are available from the corresponding author on reasonable 
request.
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Supplementary Figure 1 
Flow cytometric analysis of mesenchymal markers on ENFs and EPFs. 





embryos, and subjected to flow cytometric analysis. b, Sytox blue was used to exclude dead cells, and APC-conjugated lineage 
markers (CD45, CD31, Ter119, EpCAM, Tie-2, Lyve-1) were used to exclude non-mesenchymal cells. c-e, representative analysis plots 
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(g) within Lin
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Supplementary Figure 2 
Expression of mesoderm markers on ENFs and EPFs by immunofluorescence staining. 




 neonates (P1), and stained with primary antibodies against mouse FABP4 (a), Dlk1 
(b), Sca1 (c), SMA (d), TNC (e), and CD26 (f), and AF647-conjugated respective secondary antibodies. Depicted are representative 
high-power images of AF647 channel for antibodies (left), GFP-RFP channels for ENFs-EPFs (middle), and merged channels (right). 
Dotted lines indicate the border of epidermis and dermis, and the border of upper dermis (UD) and lower dermis (LD). Squares indicate 





Supplementary Figure 3 
EPFs associate with Collagen I fibers. 




 embryos. e-h, EPF- or ENF-
signal-derived ROI mean grey value (mgv) ± SEM of the Collagen I signal from anterior or posterior regions of E11.5 (e), E12.5 (f), 




 embryos. n = 3 optical fields of anterior and posterior regions at each development stage.  
Two-tailed unpaired t-test. * p<0.05. Scale: 50 μm. Images represent 1 out of three optical fields. The exact p values are listed in 




Supplementary Figure 4 
EPFs actively displace provisional ENF dermis. 




 embryo (up). Max projection of 
whole live embryo showing the area analyzed (down). Scales: 100 μm and 500 μm, respectively. Images are taken from the one 




Supplementary Figure 5 
Fractal analysis of ENFs organizations during development. and subsampled fractal analysis. 
a, Graphical representation of the quantitative assessment of complexity and porosity in 2D images by Fractal analysis. b, 





embryos. c, Fractal dimension (up) and lacunarity (down) values derived from ENFs of different regions and developmental stages. 
Mean ± SEM. n = 9 optical fields of anterior or posterior regions at each developmental stage. RM ANOVA, p<0.05, Newman-Keuls 




 embryos (left). 
Scale: 50 µm. e, Fractal dimension (up) and lacunarity (down) values derived from ENFs of different regions and developmental stages, 
n > 60 subsampled values pooled from three confocal images. ANOVA, Tukey test, *p<0.05. Box and whiskers plots with minimum, 




Supplementary Figure 6 
Fibronectin matrix stiffens concurrent with EPF expansion. 




 embryos. e-h, Representative 
linear profiles of diagonal lines on the Fibronectin signal from E11.5 (e), E12.5 (f), E14.5 (g), or E16.5 (h) images. Dashed lines above 




Supplementary Figure 7 
The fibroblastic lineage replacement drives the transition of dermal response to injury from regeneration to scarring. 
ENFs are the primary sculptors that drive dermal lattice development and regeneration during early development, and that their cell 
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Scars are more severe when the subcutaneous fascia beneath the dermis is injured upon
surgical or traumatic wounding. Here, we present a detailed analysis of fascia cell mobili-
sation by using deep tissue intravital live imaging of acute surgical wounds, fibroblast lineage-
specific transgenic mice, and skin-fascia explants (scar-like tissue in a dish – SCAD). We
observe that injury triggers a swarming-like collective cell migration of fascia fibroblasts that
progressively contracts the skin and form scars. Swarming is exclusive to fascia fibroblasts,
and requires the upregulation of N-cadherin. Both swarming and N-cadherin expression are
absent from fibroblasts in the upper skin layers and the oral mucosa, tissues that repair
wounds with minimal scar. Impeding N-cadherin binding inhibits swarming and skin con-
traction, and leads to reduced scarring in SCADs and in animals. Fibroblast swarming and N-
cadherin thus provide therapeutic avenues to curtail fascia mobilisation and pathological
fibrotic responses across a range of medical settings.
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Organisms such as planaria, hydra, zebrafish and certainamphibians, are able to fully regenerate tissues andorgans upon injury with minimal scarring. However, the
global mammalian and human response to injury is scarring and
contraction over the wound. Scars replace the original connective
tissue foundation with dense “plugs” of matrix fibres that tighten
the tissue and reduce its flexibility1,2. Scarring occurs both after
accidental injuries and after surgery in over 100 million patients
per year and particularly among children, one in five of whom
require reconstructive surgery for scar-induced contracted
joints2–5. Scarring and impaired wound-healing are major clinical
problems and a tremendous burden for patients and global
healthcare systems, costing tens of billions of dollars per year in
the US.
Whereas deep skin wounds trigger the subcutaneous fascia to
form exuberant scars, there are rare examples where skin injuries
culminate in scarless regeneration. Scarless regeneration is pre-
valent during foetal life as well as in certain anatomic locations
such as the oral mucosa6,7. The African spiny mouse (genus
Acomys)8 is another rare example of a mammalian species that
can regenerate skin wounds without scarring. Despite extensive
study into scarring, the underlying mechanism of how scars
emerge remains incompletely understood. Understanding this
universal wound-repair event would allow us to control, restore
and preserve the functions of physically damaged adult tissues
and pave the way towards clinically regenerating severe skin
injuries.
Recent studies have uncovered fibroblasts with distinct poten-
cies based on their lineage origins in certain skin locations9–14. For
example, we found that fibroblasts with scar-forming potential
coexist with “ordinary” fibroblasts in the adult back-skin12,13.
Scarring ability of fibroblasts is instilled during embryogenesis in
cells with temporary early embryonic expression of the Engrailed-
1 gene. In adults the scar-forming and non-scar-forming fibro-
blasts are thus referred to as the embryonic “engrailed-past” and
“engrailed-naive” fibroblasts, EPFs and ENFs, respectively. We
recently found that subcutaneous fascia, a viscoelastic membra-
nous sheet of matrix, that creates a thin gelatinous and frictionless
interface between the skin and the body’s interior rigid structures,
is the main anatomical contributor to exuberant scars that form
following deep skin wounds9. We have shown that injury induces
fascia mobilisation across the skin, and that fascia mobilisation
repairs breaches in the structural continuums of the skin, thereby
preserving skin integrity and function. It remains unclear why
fascia EPFs are prone to form scars, whereas upper dermal or oral
mucosa fibroblasts do not.
In this study, by using intravital probing into deep wounds of
live mice and an ex vivo explant technique termed scar-like tissue
in a dish (SCAD) coupled with genetically traceable scar-forming
EPFs, we show that upon wounding fascia EPFs upregulate
N-cadherin, which is required for the collective migration and
subsequent swarming of fascia EPFs towards wound centre and
drives scar formation. Blocking N-cadherin by peptide inhibitor
or genetic modification reduces scarring.
Results
Collective migration of fascia EPFs in deep wounds. First, we
looked into the composition of fascia fibroblasts during wound
healing and scarring. We previously discovered that scars developed
from a specific type of fibroblast that temporarily expressed
Engrailed-1 early in embryogenesis (termed EPFs). Whereas ENFs
that have no history of Engrailed-1 expression, do not contribute to
scar formation in any way12,13. We followed the fates of these two
fibroblast lineages by crossing fibroblast lineage-specific promoter
mice (En1Cre) to mice (R26mTmG) with a dual fluorescence reporter
that replaces membrane-bound tdTomato with membrane-bound
green fluorescence protein (GFP) upon recombination. In all, 5-mm
full-thickness excisional wounds were created on the back of
En1Cre;R26mTmG mice with biopsy punches. The excision went
through the panniculus carnosus muscle and fascia completely. The
wounds were splinted with silicone rings to minimise contraction
and to allow healing through granulation and re-epithelialization,
similar to human skin wounds. To zoom into subcutaneous fascia,
we made transverse cross-section of wounds 7 days after wounding
and examined the sections that were surrounded by panniculus
carnosus of the adjacent normal skin. EPFs were clearly clustered at
the wound centre (Fig. 1a), and were enriched from 65.6 ± 6.2% in
uninjured subcutaneous fascia (Fig. 1b and Supplementary Fig. 1) to
85.3 ± 1.7% in day-7 wounds (Fig. 1b). Fascia EPFs that clustered at
wound centres were 76.6 and 52.2% positive for the myofibroblast
markers α-SMA and DLK-1, respectively (Fig. 1c).
To visualise how fascia EPFs become enriched in late wounds
and in scars, we analysed physiological wounds using intravital
microscopy coupled with a skin chamber that was placed over a
full-thickness back-skin wound in En1Cre,R26mTmG reporter
mice. 3D snapshots of the whole in vivo wound at 14 days
post-injury (dpi) clearly showed EPFs were enriched in wound
centres, where they aggregate into a swarm eye that is devoid of
ENFs (Fig. 1d). Supplementary Movie 1 shows a high-resolution
6-h intravital live recording of fascia EPFs at the leading front of
the swarm (Supplementary Movie 1). Particle image velocimetry
(PIV) analysis revealed that individual foci of EPFs join into large
collective swarms that move towards wound centres (Fig. 1e).
Prediction measurements of cell orientations (see Methods
section) showed that EPFs collectively align themselves towards
the leading front as a group (Fig. 1f and Supplementary Movie 2).
Furthermore, cell trajectory measurements clearly demonstrated
fascia EPFs migrated collectively in physiologic wounds towards
the wound centre (Fig. 1g).
Fascia EPFs swarm to form scars. Intravital live imaging in
animals is limited to 6-h intervals, revealing only fragments of
scarring event. In order to visualise the entire scarring process, we
invented an ex vivo skin-fascia explant culture technique termed
as SCAD.
In brief, we excised and incubated 2-mm full-thickness mouse
skin discs that included the epidermis, dermis, panniculus
carnosus and subcutaneous fascia, with the fascia side facing
upwards (Supplementary Fig. 2a). Under these conditions, skin-
fascia explants developed uniform scars over a course of 5 days
(Fig. 2a and Supplementary Fig. 2b). The technique worked with
skin grafts of all ages from embryonic day 18.5 to adult
(Supplementary Fig. 2c). These were bona fide scars by several
different parameters. Histologic sections revealed masses of
fibroblasts that developed increasingly woven connective tissue
that bridged between skin folds. The fascia fibroblasts created a
plug of collagen fibres that progressively formed scars (Fig. 2a,
Day 5). 3D-immunolabelling of fibrillar matrix proteins revealed
abundant fibronectins and collagen I aligning within ex vivo scars,
with no elastin, just like in animals (Supplementary Fig. 3a, b).
More conclusively, fractal analysis12 of extracellular matrix lattice
arrangements indicated that our ex vivo scars are structurally
identical to those developing in animals, with similar lattice
complexity and porosity values (Supplementary Fig. 3c, d). Mass
spectrometry-driven proteomic analysis and subsequent String
protein–protein interaction network analysis revealed a similar
matrix protein composition and protein–protein interaction
between SCAD and in vivo scars (Supplementary Fig. 3e, f and
Supplementary Data 1). Unlike reconstructed 3D skin models,
SCADs contained most skin and fascia cell types including
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leucocytes, macrophages, lymph and blood vessels, adipocytes,
panniculus carnosus muscle, pigmented melanocytes and β3-
tubulin positive nerve bundles, and their native microenviron-
ments at unprecedented resolution during wounding (Supple-
mentary Fig. 4a–g). When SCADs made from En1Cre;R26mTmG
mice, where EPFs and ENFs were distinctly labelled green and red
respectively, EPFs were the major contributor to scar (Supple-
mentary Fig. 4h, i), and expressed myofibroblast markers α-SMA
and DLK-1 (Supplementary Fig. 4j, k), exactly as in animals
(Fig. 1a, b, d). α-SMA expression in EPFs was initially low (3.6 ±
2.7%) but substantially increased in SCADs on day 5 (41.3 ±
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in physiologic wounds (Supplementary Fig. 5). Collectively, these
data demonstrate that SCADs have scars with identical matrix
structure and protein composition, the same diverse cell types,
fibrogenic cell origins and identical surface markers to in vivo
fascia scars.
Having found that mobilisation of fascia tissue leads to scars in
wounds, and can be studied ex vivo, we set out to view how fascia
is mobilised and form real scars using multi-photon live imaging
microscopy in SCAD.
Fractal analysis of SCADs from genetically labelled mice
indicated that fascia EPFs uniquely increase intercellular con-
nectivity within several hours after injury. Certain regions had a
simple porous structure, indicative of healthy fascia, whereas other
areas developed a complex and smooth architecture, characteristic
of an early stage scar in physiologic wounds (Supplementary
Fig. 6a–c). In order to view the onset of fascia EPF migration, we
generated chimeric SCADs where the interior part of the 4-mm
tissue with green-labelled EPFs was replaced with 2-mm red-
labelled tissue from a separate transgenic mouse. This mixing of
tissues allowed single fascia EPFs to be clearly visualised as they
entered the red-only inner tissue. The fascia EPFs clearly invaded
the inner circle as aggregates within 24 h and each aggregate of
EPFs moved collectively as a group (Supplementary Fig. 6d and
Supplementary Movie 3).
Fig. 1 Collective migration of fascia EPFs in physiological in vivo wounds. aMasson’s trichrome staining and fluorescence images of vertical sections and
transverse cross sections of wounds at 7-dpi from En1Cre,R26mTmG mice. EPFs were shown in green, ENFs in red, nuclei stained with DAPI in blue. The
yellow dashed lines in vertical sections indicate the position of the cross sections. b EPF enrichment index in uninjured normal fascia or wounded fascia.
Mean ± SD, p= 0.0019, unpaired two-tailed t-test, n= 4. c Immunolabelling of α-SMA or DLK-1 in magenta of boxed area showed in a, and quantification
of the percentages of α-SMA+ or DLK-1+ cells in EPFs and ENFs. Mean ± SD, unpaired two-tailed t-test, p= 0.0001 (α-SMA), p= 0.001 (DLK-1), n= 5.
d 3D image of in vivo wound at 14-dpi on the back of En1Cre;R26mTmG mice. White boxes indicate field of view for intravital live imaging (Supplementary
Movie 1) and particle image velocity (PIV) analysis. Images are representative of three biological replicates. e PIV analysis of EPF migration over the
indicated time. The colour-coded vectors indicate the direction and displacement in pixels. f EPF channel of the first and last frames of the intravital
recording (Supplementary Movie 2). The yellow dash lines indicate the leading front of invading fibroblasts, purple lines are predicted EPF cell orientation.
g Contour lines are smoothened EPF leading front in selected frames from the intravital recording. Colours indicate time, bright for the beginning (t0) and
dark for the end (tf). Cyan lines are predicted trajectories of EPF swarm that are perpendicular to contour lines. Scale bars: a, b, d= 500 µm; e, f= 50 µm.
x–y x–ze′ f ′e f
d 60–90 min 30–60 min 120–180 mind″d′
b c0:00 h 12:00 h
Day 0 Day 5a
221813940
x-y x–z
Fig. 2 Fascia EPFs swarm during scarring in SCAD. a Whole-mount bright-field images and Masson’s trichrome staining with collagen in blue of fresh
SCAD (day 0) and after 5-day culture (day 5). n > 1000. b, c Snapshots of live imaging of day 3 En1Cre;R26mTmG SCAD. Two independent EPF aggregates
are encircled with a dotted line at time t= 0 h (b) and t= 12 h (c) (Supplementary Movie 4). Images are representative of four biological replicates. d PIV
analysis of GFP channel from live imaging showed in Supplementary Movie 4. Arrowheads indicate the direction of particle movement. Particle velocity is
indicated by a scale from slow (blue) to fast (red). Scale bar unit: pixel. d′–d″ Vector map from PIV analysis of the left swarm over 30–60min (d′) and of
the right swarm over 120–180mins (d″). e, f Colour-coded tracking of EPFs from live imaging (72–96 h) of En1Cre;R26LSL-H2B-mCherry SCAD, from top view
(e) and side view (f). Colours indicate time, starting from blue to red at the end of the movie (Supplementary Movie 6). e′ Enlarged images of EPF
migration tracks in the scar centre at the beginning of swarming (blue-to-cyan). f′ Enlarged images of EPF migration tracks at the end of swarming (green-
to-orange). Images are representative of four biological replicates. Scale bars: a= 500 µm; b, c, e, f= 50 µm; e′, f′= 30 µm.
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By day 3, we frequently observed several distinct swarm
clusters varying in size within a single SCAD. At least 4 swarms
could be seen in Supplementary Movie 4. Two large swarms from
SCADs were outlined at the 72 h and 96 h of the scarring process
in Fig. 2b, c. Individual EPF swarms had various speeds and they
changed direction regularly with a periodicity between one to two
hours (Fig. 2d–d″).
To map the overall cell trajectory of all the EPF swarms, we
wanted to move from manual to computational cell tracking, but
the highly variable shapes of fibroblasts makes this difficult. We
therefore crossed our fibroblast lineage-specific promoter mice to
a nuclear mCherry reporter line and imaged SCADs from the
offspring. Strikingly, all fascia EPFs coalesced into a single mega-
swarm by day 4 (Fig. 2e, f). Fascia EPFs at the periphery moved
towards the centre (Fig. 2e, e′). Once at the centre, fascia EPFs
migrated vertically and towards the epidermis, generating a
swarm eye of densely packed EPFs that contracted the skin from
all sides (Fig. 2f, f′). The top view in Supplementary Movie 5
showed the collective movements of EPFs (mCherry-positive
nuclei), as a single swarm across the dermis and the side view in
Supplementary Movie 6 showed migratory tracks of EPFs towards
epidermis.
Having discovered fibroblast swarms during back-skin scar-
ring, we went on to investigate if swarms occur in the oral
mucosa, an anatomic region that lacks fascia tissue and heals with
minimal scarring, unlike the back-skin. We used a reporter mouse
that permanently labels Wnt1-lineage positive fibroblasts (WPFs)
that heal wounds in cranial skin and oral mucosa7,13. We crossed
fibroblast lineage-specific reporter mice (Wnt1Cre) to R26mTmG
mice and made SCADs from the buccal mucosa of double-
transgenic offspring (Wnt1Cre;R26mTmG). These tissues had no
scars and minimal bundles of aligned collagen (Fig. 3a, b).
WPFs remained intermixed with other fibroblasts at all time
and did not form pre-scar aggregates, compared to EPFs in back-
skin SCADs (Fig. 3c–e). WPFs remained at ~50% in oral SCADs
throughout the 5 days (Fig. 3e), similar to healthy oral mucosa.
To analyse the complete migration dynamics of WPFs at the
whole-tissue level, we crossed Wnt1Cre and nuclear mCherry
reporter mice and made SCADs from buccal mucosa of the
offspring. The migration and computational tracking of WPFs as
showed in Supplementary Movies 7 and 8 respectively, revealed
that oral mucosa fibroblasts moved stochastically without
migrating in any particular direction, i.e., completely unlike
fascia EPFs from back-skin (Fig. 3f–h). Oral mucosa fibroblasts
migrated at around half the speed of back-skin fascia EPFs
without the periodic shrivelling and relaxation seen in back-skin
(Fig. 3i). Oral mucosa fibroblasts also did not swarm together
(Supplementary Movie 9) and did not generate the same tensile
forces and tissue bending movements as back-skin fascia EPFs.
Thus, the swarming that causes scarring is an exclusive feature of
the scar-forming fascia EPFs.
Our in vivo and ex vivo imaging and analyses revealed a
collective migration pattern of fascia EPFs in wounds that build in
a crescendo, with individual foci of EPFs joining into large
collective swarms. Overall the collective swarms were remarkably
similar when viewed by intravital imaging deep in mice and when
viewed in ex vivo SCAD cultures.
Fibroblast swarms are driven by N-cadherin. Since fascia EPFs
swarm during scar formation, we reasoned that they must require
an adhesion molecule to aggregate. Cell adhesion is a calcium-
dependent process. We therefore tested our hypothesis by inhi-
biting cell–cell adhesion in SCADs with the Ca2+ chelator EGTA.
The blockage of Ca2+ signalling resulted in significantly reduced
scarring (Supplementary Fig. 7a).
To determine which specific adhesion molecule was involved in
swarming, we tested a panel of candidates for co-localisation with
fascia EPFs in the scar area and found a clear co-localisation of
N-cadherin (Fig. 4a). Among other adhesion molecules, notably
integrins failed to co-localise (Supplementary Fig. 7b–d). How-
ever, the downstream effector of N-cadherin, α-catenin, did co-
localise with fascia EPFs and N-cadherin in the scar area,
consistent with a potential role for this molecule in swarming and
scarring (Supplementary Fig. 7e). N-cadherin was minimally
expressed by fascia EPFs upon wounding and was upregulated
during the healing and scarring process (Fig. 4a and Supplemen-
tary Fig. 7f, g).
In contrast, WPFs in oral SCADs minimally expressed
N-cadherin (Supplementary Fig. 7h). We therefore specifically
blocked N-cadherin in En1Cre;R26mTmG SCADs with 500 µg/ml
Exherin, a synthetic peptide that selectively inhibits
N-cadherin15,16. Under Exherin treatment, EPFs refrained from
aggregating and remained dispersed in the fascia and skin
bending and folding was completely inhibited (Fig. 4b, c). Exherin
treatment also abolished the wound-induced upregulation of α-SMA
expression in fascia EPFs (Supplementary Fig. 5). Furthermore, the
Exherin-treated tissues had profoundly altered expression pattern of
decorin (Fig. 4d, d′), a marker of scar matrix assembly that binds to
collagen fibrils17. Indeed, we observed that non-treated tissues had
densely packed fascia EPFs with organised collagen I fibres, whereas
Exherin-treated tissues had a mixed “salt and pepper” pattern of
granular collagen deposition without uniform fibre bundles (Fig. 4e).
Supplementary Movie 10 demonstrated this “salt and pepper” pattern
of collagen was throughout the entire Exherin-treated SCAD.
Correspondingly, Exherin-treated SCAD showed minimal scar by
histology (Fig. 4f, g) and distinct collagen fibre arrangements to
control scars by fractal analysis (Fig. 4h). These specific effects of
Exherin were not due to increased cell death (Supplementary Fig. 7i,
j) or reduced proliferation of EPFs (Supplementary Fig. 8a–c). In fact,
the cell proliferation was not essential for the initial stage of scar
formation (Supplementary Fig. 8d).
Compared to the mega-swarms and centripetal movements
seen in control SCADs and in animals (Fig. 2e and Supplemen-
tary Movie 5), Exherin-treated fascia EPFs had greatly diminished
collective migration (Fig. 4i and Supplementary Movie 11).
Overall, these data demonstrate unequivocally that N-cadherin
facilitates the fibroblast swarming that leads to and links fascia
mobilisation in wounds with scarring.
N-cadherin drives scarring in animals and in human skin. To
test if our mechanistic findings from SCADs occur in animals, we
first generated full-thickness wounds on backs of animals and
found that the dynamic upregulation of N-cadherin in in vivo
wounds mimics N-cadherin expression found in SCADs, with
minimal expression in healthy skin and significantly elevated
expression in day-7 and day-14 wounds, which co-localised with
EPFs in scars (Supplementary Fig. 9).
We injected AAV6 viral particles expressing Cre recombinase into
the fascia surrounding wounds in N-cadherin floxed mice (Ncadfl/fl),
which contains loxP sites flanking exon 1 of the N-cadherin gene.
Thereafter, the transduced Cre-expressing fascia fibroblasts around
wounds lost N-cadherin. As compared to the control virus, the Cre-
expressing virus resulted in 65% reduction of N-cadherin expression
in the scar region (Fig. 5a, b), and reduced scar area and width,
evidenced by whole-mount macroscopic and histologic analyses
(Fig. 5c–f). More importantly, transverse histologic views of scars
clearly demonstrated that the centripetal pattern of collagen fibres
around scar centres was disrupted by the N-cadherin patchy
knockout (Fig. 5e lower panel). Fractal analysis measurements of
control scars showed typical high fractal dimension (FD) and lower
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lacunarity (L) values in scars as compared to adjacent normal skin
(Fig. 5g).
N-cadherin knockout scars had a significantly more porous and less
complex lattice (Fig. 5g), indicating that loss of N-cadherin improves
wound quality.
To further confirm the essential role of N-cadherin in swarming
that leads to scarring, we used an independent strategy to locally
patchy knockout N-cadherin using CRISPR-Cas9. AAV6 viral
particles expressing guide RNA targeting murine N-cadherin exon
1 or control virus were injected into the fascia surrounding wounds
of full-body Cas9-expressing R26Cas9 mice. N-cadherin down-
regulation substantially reduced scar size in animals, as evidenced
macroscopically and histologically (Supplementary Fig. 10). We
further crossed En1Cre mice with Cas9 knock-in mice to generate
offspring in which only EPFs express Cas9. We locally knocked out
N-cadherin in fascia EPFs by injecting viruses expressing specific
guide RNA into the fascia surrounding wounds. Similar to our
previous two experimental models, specific loss of N-cadherin in
EPFs resulted in smaller scars and disrupted EPF swarming in
animals (Supplementary Fig. 11).
To test if the N-Cadherin mechanism seen in SCADs and mice
is clinically relevant, we generated SCADs from human skin-
punch biopsies from eyelids or from thigh-wound margins.
SCADs made from human tissues behaved in the same way as
mouse. Human SCADs contracted and curved over 14 days, and
ultimately stiffened with scars (Fig. 6a, b). As in mouse SCADs,
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Fig. 3 Fibroblast swarms are absent from oral mucosa SCAD. a, bWhole-mount bright-field image (a) and Masson’s trichrome staining (b) of SCAD from
buccal mucosa. n > 30. c, d Fluorescence images of SCAD from Wnt1Cre;R26mTmG buccal mucosa (c) and En1Cre;R26mTmG back-skin (d). e EPF and WPF
enrichment index in day 5 En1Cre;R26mTmG dorsal SCAD or Wnt1Cre;R26mTmG oral SCAD, respectively. Mean ± SD, unpaired two-tailed t-test, p= 0.0001,
n= 7/6. f, g Colour-coded tracking of WPFs in oral SCAD (f, Supplementary Movie 8) or tracking of EPFs in dorsal SCAD (g) on a mCherry nuclear
reporter (72–96 h). The colour indicates the time, with purple at the beginning and red at the end of the movie. Images are representative of three
biological replicates. h Movement similarity between WPF and EPF tracks is visualised in a scale from 0 (red, uniform migration) to 90 (blue, random
migration). i Comparison of velocities of WPFs in oral SCADs (blue) versus fascia EPFs in dorsal SCAD (orange) over time. Lines shown are smoothing
lines over all velocity values at each time point. Scale bars: a= 500 µm; b= 200 µm; c, d= 50 µm; f, g= 30 µm.
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N-cadherin expression within the contracted human SCADs
overlapped with fibroblast aggregates (Fig. 6c).
We also examined the expression of N-cadherin in primary
human hypertrophic breast scars (Fig. 6d) by whole-mount
immunostaining. N-cadherin was highly expressed in scar fibroblasts
directly beneath the epidermis, (Fig. 6e–e″, Supplementary Movie 12).
N-cadherin-positive fibroblasts aligned in fibres in the more mature
scar tissue in the deepest areas (Fig. 6e″′ and Supplementary
Movie 12). Adjacent normal breast skin had healthy dermal patterns
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Discussion
We recently demonstrated that the key scar-forming cells reside
deep in the subcutaneous fascia9 but their movements had not
been visualised in real-time and the mechanism was not explained.
Here we used in vivo and ex vivo live imaging to uncover their
novel mode of movement and key molecular player and can thus
propose a model of mammalian scarring involving N-cadherin
expression and cell swarming towards formative scar centres
Fig. 4 Fibroblast swarms are driven by N-cadherin. 3D immunolabelling of N-cadherin (magenta) in control (a) or 500 µg/ml Exherin treated
(b) En1Cre;R26mTmG SCAD. c EPF enrichment index in control or Exherin-treated SCAD. Mean ± SD, p= 0.0001, unpaired two-tailed t-test, n= 8. 3D
immunolabelling of decorin (d) or collagen I (e) in a control (upper panel) or Exherin-treated (lower panel, Supplementary Movie 10) SCAD. d′ High
magnification of white box in d. f Masson’s trichrome staining of control (upper) or Exherin-treated (lower) SCAD. g Scar areas of control, or DMSO
treated or Exherin-treated SCADs. One-way ANOVA Tukey’s test, p= 0.0008, n= 3/6/9. h Fractal dimension analysis of control, or DMSO treated
or Exherin-treated SCADs. One-way ANOVA Tukey’s test, p= 0.0001, n= 3/7/7. i Colour-coded tracking of fascia EPFs from live imaging (72–96 h) of
500 µg/ml Exherin-treated En1Cre;R26LSL-H2B-mCherry SCAD. Colours indicate time, starting from blue to red at the end of the movie (Supplementary























































































































































Fig. 5 N-cadherin is crucial for scar formation in vivo. N-cadherin was locally knockout around wounds on Ncadfl/lfl mice by injection of Cre-expressing
AAV6-Cre-GFP virus. AAV6-GFP virus served as control. a Immunolabelling of N-cadherin on transverse cross-sections of harvested scars on 14-dpi. GFP
indicates transduced cells. Dash lines outline the scar edges. b N-cadherin expression in GFP+ cells based on immunofluorescence analysis. Data are
normalised on the mean of N-cadherin expression in AAV6-GFP wounds. Mean ± SD, n= 5, p= 0.0003, unpaired two-tailed t-test. c Stereomicroscopic
images of AAV6-Cre-GFP and AAV6-GFP treated scars at 14-dpi. The yellow dash lines indicate the scar edge. d Quantification of scar area based on
histomorphometric analysis. Mean ± SD, n= 8, p= 0.0002, unpaired two-tailed t-test. e Masson’s trichrome stained vertical (upper panel) and transverse
(lower panel) sections from AAV6-Cre-GFP and AAV6-GFP treated scars. The dash lines indicate scar width. f Quantification of scar width based on
histomorphometric analysis. Mean ± SD, n= 5, p= 0.001, unpaired two-tailed t-test. g Fractal dimension and lacunarity analysis of AAV6-Cre-GFP and
AAV6-GFP treated scars and adjacent normal skin. Mean ± SD, one-way ANOVA Tukey’s test, n= 8, p values from multiple comparisons are shown in the
graph. Scale bars: a, d= 200 µm; b= 500 µm.
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(Fig. 7). Fascia EPFs upregulate N-cadherin upon wounding. The
elevated intercellular adhesion is required for the aggregation and
collective migration of fascia EPFs, and subsequent swarming
towards wound centres. Swarming of fascia EPF triggers fascia
mobilisation into wounds, contracts the skin and drives scar for-
mation. In the tissues without fascia (eg. oral mucosa) or when N-
cadherin is inhibited chemically (eg. Exherin) or genetically, fascia
EPF swarming is absent, resulting in minimal scars.
The here proposed wound-induced mechanism helps to
expound a series of earlier observations that indicate the provi-
sional granulation tissue padding the wound bed is not respon-
sible for contraction but rather that the active contraction comes
from outside of the wound18. Indeed, excisions of the wound
edge, which would disrupt swarming behaviours, relax skin
contraction19.
N-cadherin has been shown to play a critical role in the
invasion and migration of spheroid-myofibroblast aggregates into
Collagen I gel or Matrigel in vitro20. Fibroblasts from Crohn’s
disease strictures express enhanced levels of N-cadherin and
N-cadherin overexpression has been shown to enhance fibroblast
migration in vitro21,22. Previous studies also suggest wound-
induced TGF-β1 signalling could be a trigger of elevated adherens
junctions20,21. In addition, it has been demonstrated recently that
































Fig. 6 N-cadherin is involved in scar formation in human skin. a, b whole-mount bright-field image and Masson’s trichrome staining of SCADs made from
human eyelid skin (a) or thigh skin (b) 14 days after culture (middle). The histology of respective fresh SCADs is shown in right column. n > 100.
c Immunolabelling of N-cadherin (red) and FSP1 (green) of human SCAD at day 0 and day 14. d–g Masson’s trichrome staining and 3D immunostaining of
N-cadherin on biopsy from human breast hypertrophic scar (d, e) or adjacent breast skin (f, g). N-cadherin (magenta), SHG (cyan). The enlarged images













Fig. 7 Scheme of N-cadherin mediated fascia EPF swarms upon wounding and scarring. upon deep wounding, fascia EPFs assemble into aggregates and
migrate collectively towards wound centre and then swarm towards epidermis by N-cadherin (purple) mediated cell-cell adhesion. Fascia EPF swarming
triggers fascia mobilisation into wounds, contracts skin and drives scar formation. EPF swarms are absent in the tissues without fascia (e.g. oral mucosa) or
when N-cadherin is inhibited by chemicals (eg. Exherin) or genetic mutations. The absence of collective migration of fascia EPF swarms results in less scar
formation.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19425-1 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:5653 | https://doi.org/10.1038/s41467-020-19425-1 | www.nature.com/naturecommunications 9
catenin. The adherens junctions stabilised by N-cadherin, β-
catenin and p120-catenin appear to be crucial for the collective
brain infiltration of glioma cells23. The exact molecular trigger of
N-cadherin upregulation that drives fascia mobilisation requires
further investigation.
The fascia system is not only present in skin. It is a continuous
viscoelastic matrix that attaches, encloses, separates and inter-
penetrates all tissues and organs24. We therefore believe that
fibroblast swarming is likely a general fibroblastic response to
injuries in mammalian tissues and organs and not restricted to
back-skin. Support to this tenet comes from functional experi-
ments and in silico data from kidney and lung fibrosis. In these
two models of fibrosis, Cadherin-11 is upregulated on fibroblasts
in their connective tissues, and also serves as a translational
biomarker for kidney fibrosis25. Cadherin upregulation in fibro-
blasts is directly linked to their invasion during lung fibrosis26–28.
Fibroblast swarms within the injured internal organs may thus
contribute to scarring in the same way as shown here in skin.
The recruitment of the fascia into wounds by fibroblast swarms
has enormous clinical significance and opens a novel therapeutic
space. Strategies that inhibit fascia fibroblast swarms from
developing, for example by blocking the key molecule N-cad-
herin, could lead to therapeutics for preventing or reducing scar
formation in human wounds.
Methods
Mice. C57BL/6J, En1Cre, Wnt1Cre, ROSA26LSL-H2B-mCherry (R26LSL-H2B-mCherry)29
(JAX #023139), ROSA26iDTR (R26DTR) (JAX #008040), N-cadherin floxed
mice Ncadfl/fl (JAX #007611, B6.129S6(SJL)-Cdh2tm1Glr/J) and Cas9
knock-in mice R26LSL-Cas9-knockin (JAX #026175, B6J.129(B6N)-Gt(ROSA)
26Sortm1(CAG-cas9*,-EGFP)Fezh/J) strains were obtained from Jackson laboratories.
The ROSA26mTmG (R26mTmG) reporter mice were from Stanford University. En1Cre
or Wnt1Cre transgenic mice were crossed with R26mTmG or R26LSL-H2B-mCherry
reporter mice. Cas9-expressing Gt(ROSA)26Sortm1(Cas9)Rad (R26Cas9) mice were
obtained from R. Rad (Institute of Molecular Oncology and Functional Genomics,
Technical University of Munich, Germany). Animals were housed at the Helmholtz
centre animal facility. The rooms were maintained at constant temperature and
humidity with a 12-h light cycle. Animals were allowed food and water ad libitum.
All animal experiments were reviewed and approved by the Government of Upper
Bavaria and registered under the project ROB-55.2-2532.Vet_02-16-61 and ROB-
55.2-2532.Vet_02-19-23, and conducted under strict governmental and interna-
tional guidelines. This study is compliant with all relevant ethical regulations
regarding animal research. Both male and female mice were used in the study. For
wounding experiment with silicone splints in adult mice, the mice were wounded
during telogen hair cycle stage.
Human skin samples. Fresh human skin and scar biopsies, including 2 hyper-
trophic scars, from various anatomic locations, were collected from 71 donors
between 18 and 65 years of age, through the Section of Plastic and Aesthetic
Surgery, Red Cross Hospital Munich (reference number 2018–157), and by the
Department of Dermatology and Allergology, Klinikum rechts der Isar, Technical
University Munich (reference number 85/18S). Informed consent was obtained
from all subjects prior to skin biopsies. Upon collection, these samples were directly
processed for tissue culture or fixed with PFA and then processed for cryosection
or paraffin section followed by histological or immunofluorescent analyses.
Scar-like tissue in a dish assay. Full-thickness back-skin including fascia was
collected from C57BL/6J or two-colour membrane reporter En1Cre;R26mTmG or
nuclear reporter En1Cre;R26LSL-H2B-mCherry neonates at postnatal day 0–1, to allow
a homogeneous fascia thickness. The harvested tissue was washed twice with cold
DMEM/F-12 (Thermo Fisher Scientific 11320074) medium to remove con-
taminating blood, and then washed once with Hank’s Balanced Salt Solution
(HBSS, Thermo Fisher Scientific 14175095). After careful removal of ventral non-
skin tissue with a surgical scalpel, round skin pieces were cut out with a disposable
Ø 2 mm biopsy punch (Stiefel 270130) down to bellow the panniculus carnosus
muscle, and cultured in 200 µl of DMEM/F-12 medium containing 10% FBS, 1x
GlutaMAX (Thermo Fisher Scientific 35050038), 1x Penicillin/streptomycin
(Thermo Fisher Scientific 15140122), and 1x MEM non-essential amino acids
(Thermo Fisher Scientific 11140035) in 96-well plates, in a humidified 37 °C, 5%
CO2 incubator. (Note: the 2 mm skin pieces were cultured submerged in medium
with dermal side face up, but not floating at the liquid-air interface). Fresh medium
was supplied every other day and the skin tissues were harvested at the indicated
time points (day 1–5 after culture), with the fresh tissues serving as day 0 control,
and fixed in 2% PFA overnight at 4 °C. After washing in PBS, the tissues were
embedded and frozen in optimal cutting temperature compound and 6 µm cryo-
sections were prepared with a cryostat.
Oral SCADs were made from Ø 2-mm full-thickness cheek biopsies of neonates
(postnatal day 0–1) of two-colour membrane reporter Wnt1Cre;R26mTmG or
nuclear reporter Wnt1Cre;R26LSL-H2B-mCherry mice. Oral SCADs were cultured in a
same way as the back-skin SCADs, with buccal mucosa face up.
Human SCADs were generated by incorporating the deep dermal and
subcutaneous layers that contain fascia, but without epidermis, cultivated under
same conditions as mouse SCADs. Tissues were harvested 14 days after culture,
and processed for histology and immunofluorescence staining.
SCAD chimera assay. SCAD biopsies were taken from neonatal back-skin of
En1Cre;R26mTmG mice with a Ø 4-mm biopsy punch. Thereafter, the 2-mm centre
was excised from the 4-mm En1Cre;R26mTmG SCAD with a Ø 2-mm biopsy punch,
and replaced by a 2-mm SCAD generated from the Cre-negative littermates, in
which the entire tissue is RFP labelled. Resultant chimeric SCADs were cultured in
our standard conditions. The migratory behaviour of GFP+ EPFs into RFP+ inner
SCAD was documented by live imaging. The possibility that the injury induced
upregulation of factors that may promote migration cannot be ruled out.
LC-MS/MS proteomic analysis. Scar tissues were harvested for proteomics from
day 5 SCADs, and from in vivo 2-mm full-thickness excisional wounds on P2
neonates and at day-14 after wounding. After removing the epidermis, scar tissues
were washed, pooled and homogenised. After centrifugation, proteins were
extracted in Guanidinium Buffer (6 M Guanidinium chloride, 10 mM TCEP, 40
mM CAA, 100 mM Tris pH 8.5). Peptides from LysC and trypsin proteolysis
(1:75), were purified on SDB-RPS material stage-tips and data was acquired on a
Quadrupole/Orbitrap type Mass Spectrometer (Q-Exactive, Thermo Scientific)30.
MS raw files were processed by MaxQuant31 (version 1.5.3.20) and MaxQuant
output tables were analysed using the Perseus software suite32 (version 1.5.8.7). The
identified proteins were filtered for Matrisome proteins33. Thereafter, network
analysis was performed with Cytoscape software34 (version 3.6.1). All other sta-
tistical and bioinformatics operations, such as normalisation, heat-map generation,
string-network mapping and multiple-hypothesis testing corrections, were per-
formed with the Perseus software suite. The mass spectrometry proteomics data
have been deposited to the ProteomeXchange Consortium via the PRIDE partner
repository with the dataset identifier PXD016068.
Local N-cadherin knockout in R26Cas9 or En1Cre;R26Cas9-knockin or Ncadfl/fl
wounds. A guide RNA (gRNA) targeting exon 1 of mouse N-cadherin was
designed with the Benchling tool. The adeno associated virus serotype 6 (AAV6)
expressing gRNA targeting murine N-cadherin (TCCGGCA-
CATGGAGGCGGAG) was created by cloning gRNA into the SAP1 sites of pAAV-
U6-sgRNA-CMV-GFP (Addgene #8545135). N-cadherin gRNA expressing AAV6
(AAV6-NcadgRNA-GFP) was produced by transfecting the AAVpro 293T Cell
Line (Takara Bio 632273) with pAAV-U6-NcadgRNA-CMV-GFP, pRC6 and
pHelper plasmids from the AAVpro Helper Free System (Takara Bio 6651). Cre-
expressing AAV6 (AAV6-Cre-GFP) was purchased from Addgene (Addgene
#6854436). Transfection was performed with PEI transfection reagent and viruses
were harvested 72 h post-transfection. AAV6-NcadgRNA-GFP or AAV6-Cre-GFP
or control AAV6-GFP viruses were extracted and purified with an AAVpro pur-
ification kit all serotypes (Takara Bio 6666).
Two Ø 2-mm full-thickness excisional wounds were created on the back of
anaesthetised 13-day-old full-body Cas9-expressing R26Cas9 mice or 5 days old
En1Cre;R26Cas9-knockin mice that express Cas9 in EPFs. CRISPR/Cas9-based local
N-cadherin ablation was performed by subcutaneously injecting 20 µl of AAV6-
gRNA-GFP virus at a viral titre of 1 × 1012/ml at the area between the two wounds
(~5 mm in distance) at day 0, 5 and 10 post-wounding. The small bleb (fluid
pocket) resulted from the injection reached the edges of both wounds. The mice
received subcutaneous injection of the AAV6-GFP virus without gRNA as control.
Similarly, two Ø 2-mm full-thickness excisional wounds were created on the
back of anaesthetised 5 days old homozygous N-cadherin floxed Ncadfl/fl mice
containing loxP sites flanking exon 1 of the N-cadherin gene37. Local N-cadherin
ablation was performed by subcutaneously injecting 20 µl of AAV6-Cre-GFP virus
at a viral titre of 2 × 1012/ml at the area between the two wounds at day 0, 5 and 10
post-wounding. The fluid pocket after injection reached the edges of both wounds.
The mice received subcutaneous injection of the AAV6-GFP virus as control.
Scar tissues were harvested at day 14 post-wounding. Scar images were
documented with a Leica M50 stereo-microscope (Leica) at ×4 magnification.
Subsequently, the scar tissue was processed for cryo-sections for histology and
immunofluorescence.
Antibodies and reagent. The following antibodies were used: N-cadherin (clone
GC4, Sigma-Aldrich C3865, 1:100 dilution), FSP1 (Abcam ab58597, 1:100 dilution),
PDGFRα (R&D Systems AF1062, 1:50 dilution), Collagen I (Rockland
600–401–103–0.1, 1:150 dilution), Collagen III (Abcam ab7778, 1:150 dilution),
Fibronectin (Abcam ab23750, 1:200 dilution), α-SMA (Abcam ab5694, 1:100 dilution),
CD31 (Novus Biologicals NB100-2284, 1:500 dilution), EpCAM (Abcam ab92382,
1:500 dilution), Lyve-1 (Abcam ab14917, 1:500 dilution), Myf-5 (clone C-20, Santa Cruz
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sc-302, 1:500 dilution), CD45 (clone IBL-3/16, Abcam ab23910, 1:500 dilution), FABP4
(clone EPR3579, Abcam ab92501, 1:500 dilution), F4/80 (Abcam ab90247, 1:500
dilution), Cytokeratin 14 (clone EPR17350, Abcam ab181595, 1:200 dilution), Integrin
αv (clone EPR16800, Abcam ab179475, 1:500 dilution), α1-catenin (clone EP1793Y,
Abcam ab51032, 1:500 dilution), decorin (Abcam ab175404, 1:500 dilution), DLK-1
(Abcam ab21682, 1:200 dilution) and Ki67 (clone SP6, Abcam ab16667, 1:500 dilution).
Fluorophore-conjugated secondary antibodies were purchased from Thermo Fisher
Scientific (1:500 dilution). Exherin (ADH-1) was from TargetMol (T2637).
Masson’s trichrome staining. Cryo-sections were fixed in cold acetone (−20 °C)
for 5 min and incubated overnight in Bouin’s solution (Sigma-Aldrich HT10132) at
room temperature. After washing in cold tap water, the sections were stained with a
working concentration of Weigert’s Iron Hematoxylin (Sigma-Aldrich HT1079) for
5 min. Thereafter, the sections were treated with a Masson’s trichrome stain kit
(Sigma-Aldrich HT15) by sequentially incubating at room temperature in Biebrich
scarlet-acid fuchsin solution for 5 min, working concentration of Phosphotungstic
/Phosphomolybdic acid for 5 min, aniline blue solution for 10 min, and 1% acetic
acid for 2 min. After dehydration, the sections were cleared with Roti-Histol and
mounted with a Roti-Histokitt (Roth 6640 and 6638 respectively).
Cell counting was performed with ImageJ. Briefly, trichrome images were
converted to CMYK and the black channel was used to count the iron
haematoxylin stained nuclei. Regions of interest covering the scar area were
delimited and processed using the functions of subtract background (rolling ball=
50 px), enhance contrast (saturated= 0.1 normalised), Unsharp Mask (Radius= 2,
Mask= 0.6), Median (radius= 1) and the auto-threshold method Minimum.
Watershed function was used in the binary images and the particles were counted
(size threshold= 30–200 px2).
For the quantification of scar areas, trichrome images were converted to CMYK
and the cyan channel was used to analyse the blue-stained collagens.
Immunofluorescence staining. Cryo-sections were fixed in cold acetone for 5 min
and blocked with 5% BSA in PBS for 1 h. Thereafter, sections were incubated
overnight with primary antibodies at 4 °C. After three PBS washes, sections were
incubated with appropriate fluorophore-conjugated secondary antibodies (Thermo
Fisher Scientific) at room temperature for 1 h. For double staining, sections were
incubated at room temperature with the second primary antibody for 2 h, and
appropriate secondary antibody for 1 h. Nuclei were counterstained with DAPI for
3 min. Coverslips were mounted with Fluoromount-G (Thermo Fisher Scientific
00–4958–02). Photomicrographs were taken with a Zeiss AxioImager microscope
with AxioVision software (Carl Zeiss), or a Zeiss laser scanning microscope
LSM710 with Zen software (Carl Zeiss).
Whole-mount bright-field imaging. SCAD tissues were fixed with 2% PFA at 4 °C
overnight, and washed three times with PBS. Whole-mount bright-field images
were taken with a Leica M50 stereo-microscope (Leica) with a Leica DFC310 FX
camera (Leica) and saved with Leica Application Suite (v4.8).
3D imaging. (1) By laser scanning microscopy with tissue-clearing: whole-mount
samples were stained and cleared by a modified 3DISCO protocol. In short, fixed
samples were pre-incubated in Dulbecco’s Phosphate-Buffered Saline (DPBS,
Thermo Fisher Scientific 14190169) containing 0.2% gelatin (Sigma G1393), 0.5%
Triton-X100 (Sigma X100) and 0.01% Thimerosal (Sigma T8784) (PBS-GT), for
24 h at room temperature. Antibodies: anti-elastin (Abcam ab21610), anti-
fibronectin (Abcam ab23750) and anti-collagen type I (Rockland 600–401–103),
were pre-labelled with Alexa Fluor 488, 594 and 647 dyes (Thermo Fisher Scientific
A20181, A20184, A20186) according to the manufacturer’s instructions. The
samples were incubated, rotating, with the labelled antibodies in PBS-GT (1:1000)
for 24 h at room temperature. After washing in PBS-GT, samples were first
dehydrated in an ascending THF (Sigma 186562) series (50%, 70%, 80%, 3 × 100%;
30 min each), then cleared in dichloromethane (Sigma 270997) for 30 min and
eventually immersed in benzyl ether (Sigma 108014). Cleared samples were imaged
in 35 mm glass-bottom dishes (ibidi 81218) under a laser scanning confocal
microscope (Zeiss LSM710, Carl Zeiss, Germany). Raw data was processed and
optimised for visualisation, adjusting brightness and contrast with Imaris software
(v9.1.0, Bitplane, UK).
(2) By multi-photon microscopy without tissue-clearing: whole-mount samples
were immuno-labelled and embedded in 2% NuSieve GTG agarose (Lonza 859081)
in a 35 mm dish (Falcon 351008) and were imaged under a Leica SP8 MP (Leica,
Germany). Tiles were merged offline using the Leica Application Suite X (v4.8,
Leica) with smooth overlap blending, and data were visualised with Imaris software
(v9.1.0, Bitplane, UK) using contrast and brightness adjustments.
Live imaging using multi-photon microscopy. Full-thickness skin pieces were
collected as described above and imaged with a Leica SP8 MP (Leica, Germany). In
brief, samples were embedded in 4% agarose (Lonza, 859081) in a 35-m dish
(Corning, 351008) and submerged in imaging medium (phenol-red-free DMEM/F-
12 (Thermo Fisher Scientific, 21041025) containing 10% KnockOut Serum
Replacement (Thermo Fisher Scientific, A3181501), 1x GlutaMAX (Thermo Fisher
Scientific, 35050038), 1x Penicillin/streptomycin (Thermo Fisher Scientific,
15140122), and 1x MEM non-essential amino acids (Thermo Fisher Scientific,
11140035)). A 25x water-dipping objective (HC IRAPO L 25x/1.00W) was used in
combination with a tunable laser (Spectra Physics, InSight DS+ Single). Second
harmonic signal was collected with external hybrid photodetectors with a HC 405/
150 filter. Green, orange, red, and far-red signals were collected using a 525/50,
585/40, 624/40, and 650/50 bandpass filters.
A modified incubation system, with heating and gas control (ibidi 10915 and
11922), was used to guarantee physiologic and stable conditions during imaging
(35 °C, 5% CO2). Z-stacks were recorded in 15 min intervals.
Intravital multi-photon imaging. Dorsal skinfold chamber was implanted as
described before38. In brief, mice were anesthetised and the dorsal back skin was
shaved, depilated and disinfected. A fold of the dorsal skin was examined for major
vessels and relocated to spare them during preparation of the wound. The sterilised
skinfold chamber (APJ Trading Co, Inc; Ventura, CA) was sutured to the skin on
the upper side using 4/0 braided sutures (Chirlac #PG 0203, Vitrex Medical,
Denmark) and fixed with the three bolts and nuts. A full-thickness wound was
created in the middle of the observation window using a 3-mm biopsy punch
(Stiefel) carefully removing epidermis, dermis and panniculus carnosus layer. After
flushing with physiologic saline, a sterile coverslip was used to cover the wound.
The wound was imaged 14 days post wounding for a period of 6 h using a Leica
SP8 MP (Leica, Germany) equipped with a 25x water-dipping objective (HC
IRAPO L 25x/1.00W) and a tuneable laser (Spectra Physics, InSight DS+ Single).
Fluorescent signal was generated at 960 nm (SHG, GFP) and 1050 nm (tdTomato)
and collected with external hybrid photodetectors using the following bandpass
filters: SHG: 405/150; GFP: 525/50; tdTomato: 585/40.
Mice were anesthetised with 1–3% Isoflurane and maintained for the time of
intravital imaging. A subcutaneous depot of 200 µL physiologic saline was injected
to prevent dehydration. Mice were placed in lateral position on a heated plate and
vital parameters (ECG, respiration, rectal temperature) were monitored
continuously (75–1500, Harvard Apparatus, MA). The dorsal skinfold chamber
was fixed on a custom made metal bracket, which was stably mounted to the stage
of the microscope. A thin circular barrier of silicon grease (Korasilon, Kurt
Obermeier, Germany) was applied to the coverslip to keep the immersion water
from draining.
Orientation vector field analysis. Vector fields were generated using ImageJ
plugin OrientationJ 2.0.4 – Vector Field39. In brief, frame images of the green
channel (EPFs) from intravital microscopic recording were subjected to maximum
intensity projection. Substacks were created with every 10 frames of the recording.
Orientation vector fields were applied with vector field grid size of 150 pixels with
100% length of scale vector. Resulting vector trajectories were converted into masks
and overlaid on the original frame image.
Contour line trajectory analysis. Contour lines were derived using ImageJ plugin
Interactive 3D surface plot. Maximum intensity substacks were computed using the
frame images of the green channel (EPFs) corresponding to 0, 3 and 6 h of the
intravital microscopic recording. These frames were subjected to 3D projection
with full transparency to create a pseudo z stack. To mark the boundaries of the
pseudo z stack, contour lines corresponding to leading front of the frames were
overlaid and 3D surface plot were rendered. Contour lines were generated with
following parameters: Grid size - full size of the image, Smoothing - 130, Lighting -
0.50 and perspective - 0.0. Resulting contour lines were displayed using standard
fire lookup tables from LUT library. The gradient lines perpendicular to the
contour lines are used to predict the trajectory of migrating EPF swarms.
Automated and manual cell tracking. Automated cell tracking was performed on
SCADs made from nuclear reporter lines (En1Cre;R26LSL-H2B-mCherry or Wnt1Cre;
R26LSL-H2B-mCherry) using Imaris software package (v9.1.0, Bitplane, UK). Tracks
were generated from 4D data using the fluorescence intensity-based surface
detection tool. The resulting data that represents the nuclei of Cre-positive cells
were filtered for good quality. Tracks were visualised in a time-coded colour
representation, ranging from purple to red. Only the last 12 time points of the
respective tracks are shown for better visibility and to prevent overcrowded images
and videos.
Manual cell tracking was performed on SCADs from two-colour membrane
reporter lines (En1Cre;R26mTmG or Wnt1Cre;R26mTmG) with ImageJ using the
Manual Tracking plugin (version 2.1.1), since the cell boundaries in the membrane
reporter system can’t be accurately segmented and followed by the automatic
tracking software. In brief, the channels of 3D-Time lapse datasets were split and
subjected to maximum intensity projection. Migration of individual cells was
tracked over time. Trajectories and individual track information with coordinates
were exported as TIFF and excel file respectively. Graphical visualisation and
analysis of these trajectories were performed using R. Iterative loops to generate a
colour-ramp for each track as a function of time and embedded into respective
coordinates (Blue= first time point; Red= last time point).
Fractal analysis of images. We use fractal analysis to quantify the complexity of
cellular arrangement and extracellular matrix. In this analysis, the fractal
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dimensions and lacunarity values measure the complexity and porosity of shapes
respectively. Complex arrangements score higher fractal dimension values than
simpler arrangements, while porous structures score higher lacunarity values than
smoother ones.
Images were analysed with ImageJ (ImageJ v1.47) to produce values that were
analysed using GraphPad 6. For fractal analysis of collagens, trichrome images were
converted to CMYK and the cyan channel was used to analyse the blue-stained
collagens. Images were processed using the subtract background (rolling ball= 50
px), enhance contrast (saturated= 0.1 normalised), Unsharp Mask (Radius= 2,
Mask= 0.6), Median (radius= 1) and the auto-threshold method Default
functions. Fractal dimension and lacunarity values were calculated using the
FracLac Plugin with a pixel threshold of 0.40.
Particle image velocimetry analysis of images. Particle image velocimetry (PIV)
has been used to describe collective cell migration40. Using the ImageJ plugin41 we
performed PIV on the GFP/RFP signal from live-imaging video stacks of En1Cre;
R26mTmG dorsal SCAD or Wnt1Cre;R26mTmG oral SCADs. Successive video frames
of 30 min intervals from 24 h videos were subjected to iterative (cross-correlation)
PIV on 64 × 64, 32 × 32 and 16 × 16 pixel sub-windows. Normalised median test
(noise= 0.2, threshold= 5) post-processing was used to decrease the background
noise. Calculated magnitude vectors were then used to measure direction and
velocity.
Enrichment index, displacement, velocity and similarity measures of images.
EPF enrichment index was calculated by mean fluorescence intensity (MFI) of GFP
channel (EPF) divide by the sum of MFI of GFP channel and MFI of RFP channel
(ENF). Similarly, WPF enrichment index in oral mucosa SCAD was calculated by
MFI of GFP channel (WPF) divide by the sum of MFI of GFP channel and MFI of
RFP channel (WNF). Displacement measures were based on five landmarks
between alternate frames from live imaging. Mean displacement values were added
up and plotted versus time. Using the tracked trajectories, we calculated the dis-
tance between positions of the same cell at consecutive time points in 3D. To
measure movement similarity of neighbouring cells we first determined the
movement vector for every cell between consecutive time points. Then we com-
pared this vector to all movement vectors of neighbouring cells by calculating the
angles between these vector pairs in 3D. Finally, we averaged all angles to produce
one movement-similarity score. To identify neighbours of individual cells we
applied a Delaunay triangulation on 3D cell coordinates42.
Statistics and reproducibility. GraphPad Prism was used for all statistical ana-
lyses except proteomics. Unless otherwise indicated, mean ± SD values are reported
in the graphs. The exact statistical analyses used to quantify data, the exact values
of n, and the exact p values are stated in the respective figure legends. For sim-
plicity, p values below 0.0001 were stated as equal to 0.0001. All experiments were
performed at least three times independently with similar results.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The proteomics data have been deposited in the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier: PXD016068.
The data that support the findings of this study are available from the authors on
reasonable request.
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Injury triggers fascia fibroblast collective cell migration to drive scar formation 
through N-cadherin  
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Supplementary Figure 1. EPF and ENF composition in subcutaneous fascia.  
a, Subcutaneous fascia was separated from the back-skin of En1Cre;R26mTmG neonates (P0-
P1). Single cell suspension was prepared from the pooled fascia and subjected to flow 
cytometric analysis. Sytox Blue was used to exclude dead cells, and APC-conjugated lineage 
markers (CD45, CD31, Ter119, EpCAM, Tie-2, Lyve-1) were used to exclude non-fibroblastic 
cells. b, in living Lin- population, GFP+RFP- cells were gated as EPFs, and GFP-RFP+ cells 
were gated as ENFs. c, percentages of ENFs and EPFs in subcutaneous fascia. Mean ± SD, 
unpaired two-tailed t-test, p=0.0012, n=4. 
 
 
Supplementary Figure 2. SCAD model.  
a, Key elements of the SCAD assay include (1) back-skin from new-born mice (postnatal day 
0-1) for uniform scar formation, (2) full-thickness skin biopsy including subcutaneous fascia, 
(3) culturing with fascia side up. E, epidermis; D, dermis; PC, panniculus carnosus; F, 
subcutaneous fascia. b, Masson’s trichrome staining of cryosections of SCADs from day 0 to 
day 5 of culture. Scale bars = 200 µm. c, SCADs from mice at various development stages. 
Whole-mount images (upper panel, scale bars = 500 µm) and Masson’s trichrome staining 
(lower panel, scale bars = 200 µm) of SCADs using back-skin from embryos (E15.5, E18.5), 




Supplementary Figure 3. SCAD recapitulates characteristics of in vivo fascia scar.  
a, 3D immunostaining of fibronectin (red), collagen I (magenta) and elastin (green) in SCADs 
at low (upper panel) and high (lower panel) magnification. b, fibrillary collagens represented 
by second harmonic generation (SHG, cyan) signal in SCADs at low (upper) and low (lower) 
magnification. c, fractal dimension (left) and lacunarity (right) of day0 SCAD, day5 SCAD, in 
vivo skin, and in vivo scars. Mean ± SD, n=7/22/11/7, One-way ANOVA Tukey's test. *, 
p=0.0001; ns, not significant. d, regression lines showing similar changes in fractal values 
between SCAD and in vivo scars. e, 4438 proteins were identified by proteomic analysis. 
When filtered for Matrisome proteins, 193 proteins in SCADs and 224 proteins in in vivo 
scars remained, respectively. The pie chart shows the similar percentages of Matrisome 
proteins in the indicated categories and the Venn diagram shows the overlapping Matrisome 
proteins of SCAD and in vivo scars.  f, a protein-protein interaction network showing the 
similarity of matrix proteins between SCAD and in vivo scars. The colour coding indicates the 
abundance of proteins. Scale bars: a, b upper panel = 100 µm, lower panel = 30 µm. 
 
 
Supplementary Figure 4. Cellular component of SCAD.  
a, 3D immunolabeling of CD45 (magenta) in day0 and day5 SCADs. b-g, 3D immunolabeling 
of F4/80 (b), CD31 (red) and Lyve-1 (green) (c), FABP4 (d), Myf-5 (e), Melan A (f), and 
Tubulin 3 (magenta) and SHG (cyan) (g) in SCADs. h, i, 3D (h) and 2D (i) fluorescence 
images of En1Cre;R26mTmG SCAD, EPFs in green. j, k, 3D immunolabeling of -SMA (j) and 
DLK-1 (k) in SCAD. Images are representative of at least three biological replicates. Scale 




Supplementary Figure 5. -SMA expression in SCAD.  
3D immunolabeling of -SMA in En1Cre,R26mTmG SCAD before culture (a) or cultured 1, 3, 5 
days with or without 500 µg/ml Exherin treatment (b). -SMA in magenta, EPFs in green, and 
ENFs in red. c, quantitative analysis of percentage of -SMA+ area in respective SCAD. 




Supplementary Figure 6. Fascia EPFs aggregate in groups and migrate collectively at 
the onset of scarring. 
a, snapshot of live imaging (0-24 h) of En1Cre;R26mTmG SCAD at 24 h in culture. b, fractal 
analysis of EPFs (GFP channel). Colour code indicates fractal dimension (FD) values from 
low (dark) to high (bright). c, FD (left) and lacunarity (right) values of regions R1-R4. Mean ± 
SEM of all subsampled values in each region. One-way ANOVA, Tukey's multiple 
comparisons test, *p=0.001, n=121 samples. d, snapshots (3h, 6h, 11h) of live imaging of a 
chimeric SCAD showing the migration of fascia EPF aggregates (Supplementary Movie 3). 
White lines indicate the border between the outer En1Cre;R26mTmG SCAD and inner grafted 
RFP only SCAD. The arrows indicate the invasion of fascia EPF aggregates into the inner 
region. The yellow and white arrows indicate two independent EPF aggregates. Scale bars: a 





Supplementary Figure 7. N-cadherin mediated cellular adhesion of EPFs is essential 
for scar formation. 
a, Masson’s trichrome staining of control and 0.5 mM EGTA treated SCAD. b-e, 3D 
immunolabeling of integrin V (b), integrin 5 (c), integrin 1 (d), and -catenin (e) in 
En1Cre;R26mTmG SCAD. f-h, 3D immunostaining of N-cadherin (magenta) in day0 (f) and day2 
(g) En1Cre;R26mTmG dorsal SCAD, and day4 Wnt1Cre;R26mTmG oral SCAD (h). i, 
immunostaining of active caspase-3 in scar area of DMSO or 500 µg/ml Exherin treated 
SCAD. Cell nuclei were stained with DAPI. j, percentages of active caspase-3+ cells in scar 
area of DMSO or Exherin treated SCAD. n=3/4, p=0.4066, unpaired two-tailed t-test. Scales: 





Supplementary Figure 8. Ki67 expression in SCAD.  
3D immunolabeling of Ki67 in En1Cre,R26mTmG SCAD before culture (a) or cultured 1, 3, 5 
days with or without 500 µg/ml Exherin treatment (b). Ki67 in magenta, EPFs in green, and 
ENFs in red. c, quantitative analysis of number of Ki67+ cells in respective SCAD. Mean ± 
SD, unpaired two-tailed t-test, n = 4; n.s., not significant. d, SCAD treated with 100 µM 




Supplementary Figure 9. N-cadherin expression is elevated in EPFs in physiological 
wounds. 
H&E staining and immunolabeling of N-cadherin (magenta) in skin and in vivo wounds at day 
7 and day 14 after wounding. EPFs showed in green. e, epidermis; d, dermis; pc, panniculus 





Supplementary Figure 10. Local knockout of N-cadherin reduces scarring with full-
body Cas9 mouse model. 
Local knockout of N-cadherin in wounds on full-body Cas9 (R26Cas9) mice by AAV6 viral 
particle expressing guide RNA specific to mouse N-cadherin (AAV6-NcadgRNA-GFP). 
AAV6-GFP transduced wounds served as controls. a, immunofluorescence images of scars 
transduced with AAV6-GFP control virus (upper panel) or with AAV6-NcadgRNA-GFP virus 
(lower panel), harvested at 14-dpi. b, representative stereomicroscopic images of AAV6-
NcadgRNA-GFP and AAV6-GFP treated scars at 14-dpi. The yellow dotted lines indicate the 
scar edges. c, quantification of scar area based on histomorphometric analysis. Mean ± SEM, 
n=14/10, p=0.0002, unpaired two-tailed t-test. d, Masson’s trichrome staining of AAV6-
NcadgRNA-GFP and AAV6-GFP treated scars. The orange dotted lines indicate scar width. 
e, quantification of scar width based on histomorphometric analysis. Mean ± SEM, n=14/10, 





Supplementary Figure 11. Local knockout of N-cadherin in EPFs reduces scarring with 
Cas9 knock-in mouse model. 
Knockout of N-cadherin in EPFs around wounds on En1CreR26Cas9-knockin mice by AAV6 viral 
particle expressing guide RNA specific to mouse N-cadherin (AAV6-NcadgRNA-GFP). 
AAV6-GFP transduced wounds served as controls. a, representative stereomicroscopic 
images of AAV6-NcadgRNA-GFP and AAV6-GFP treated scars at 14-dpi. The dash lines 
indicate the scar edge. b, quantification of scar area based on histomorphometric analysis. 
Mean ± SD, n=6, p=0.0001, unpaired two-tailed t-test c, Masson’s trichrome stained 
transverse (upper panel) and vertical (lower panel) sections from AAV6-NcadgRNA-GFP and 
AAV6-GFP treated scars. The dash lines indicate scar edge or width. d, quantification of scar 
width based on histomorphometric analysis. Mean ± SD, n=6, p=0.0033, unpaired two-tailed 
t-test. e, immunolabeling of N-cadherin on transverse (upper panel) or vertical (lower panel) 
sections of scars. GFP indicates transduced cells. Dash lines outline the scar edges. Scale 




Appendix: Publication III and IV 
Publication III  
Correa-Gallegos D, Jiang D, Christ S, Ramesh P, Ye H, Wannemacher J, Gopal SK, Yu Q, 
Aichler M, Walch A, Mirastschijski U, Volz T, Rinkevich Y. Patch repair of deep wounds by 
mobilized fascia. Nature. 2019;576(7786):287-292. 
In the above work, my contributions include 3-D multiphoton imaging to visualize basic 
structural features of murine subcutaneous fascia. This includes orientation and localization of 
EPF and its associated fascial matrix in a 3-D space. The matrix diversity or ECM profile were 
visualized using label-free second harmonic generation approach (Figure 3a and extended data 
Figure 2f). 
Related publication not included in the thesis 
Fischer A, Koopmans T, Ramesh P, Christ S, Strunz M, Wannemacher J, Aichler M, 
Feuchtinger A, Walch A, Ansari M, Theis FJ, Schropp K, Hadian K, Neumann PA, Schiller H, 
Rinkevich Y. Post-surgical adhesions are triggered by calcium-dependent membrane bridges 
between mesothelial surfaces. Nature Communications 11, 3068 (2020). 
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Patch repair of deep wounds by mobilized 
fascia
Donovan Correa-Gallegos1,7, Dongsheng Jiang1,7, Simon Christ1, Pushkar Ramesh1,  
Haifeng Ye1, Juliane Wannemacher1, Shruthi Kalgudde Gopal1, Qing Yu1, Michaela Aichler2, 
Axel Walch2, Ursula Mirastschijski3,4, Thomas Volz5 & Yuval Rinkevich1,6*
Mammals form scars to quickly seal wounds and ensure survival by an incompletely 
understood mechanism1–5. Here we show that skin scars originate from prefabricated 
matrix in the subcutaneous fascia. Fate mapping and live imaging revealed that fascia 
fibroblasts rise to the skin surface after wounding, dragging their surrounding 
extracellular jelly-like matrix, including embedded blood vessels, macrophages and 
peripheral nerves, to form the provisional matrix. Genetic ablation of fascia 
fibroblasts prevented matrix from homing into wounds and resulted in defective 
scars, whereas placing an impermeable film beneath the skin—preventing fascia 
fibroblasts from migrating upwards—led to chronic open wounds. Thus, fascia 
contains a specialized prefabricated kit of sentry fibroblasts, embedded within a 
movable sealant, that preassemble together diverse cell types and matrix 
components needed to heal wounds. Our findings suggest that chronic and excessive 
skin wounds may be attributed to the mobility of the fascia matrix.
Mammalian scarring occurs when specialized fibroblasts migrate into 
wounds to deposit plugs of extracellular matrix1. Abnormal scarring 
results in either non-healing chronic wounds or aggravating fibrosis2–4, 
which represent a high burden for patients and to the global healthcare 
system. In the US alone, costs related to impaired scarring amount to 
tens of billions of dollars per year5.
The origin of fibroblasts in wounds and the mechanism by which they 
act remain unclear6. Possible sources, such as papillary (upper) and retic-
ular (lower) dermal layers7, pericytes8, adipocytes9,10 and bone-marrow 
derived monocytes11 have been suggested. We previously demonstrated 
that all scars in the back skin derive from a distinct fibroblast lineage 
expressing the engrailed 1 gene (En1) during embryogenesis and we refer 
to these cells as En1-lineage positive fibroblasts (EPFs)12,13. This lineage is 
present not only in the skin but also in the strata underneath, called fascia.
The fascia is a gelatinous viscoelastic membranous sheet that creates 
a frictionless gliding interface between the skin and the body’s rigid 
structure below. Mouse back-skin fascia extends as a single sheet sepa-
rated from the skin by the Panniculus carnosus (PC) muscle, whereas in 
humans back-skin there is no intervening muscle and the fascia consists 
of several thicker sheets that are continuous with the skin. In humans 
the facia layers incorporate fibroblasts, lymphatics, adipose tissue, 
neurovascular sheets and sensory neurons14,15.
Here we explored the fundamental mechanisms of scar formation by 
using matrix-tracing techniques, live imaging, genetic-lineage tracing 
and anatomic fate-mapping models. We identified the fascia as a major 
source of wound-native cells, including fibroblasts. Notably, we found 
that wound provisional matrix originates from prefabricated matrix in 
the fascia that homes in to open wounds as a movable sealant dragging 
along vasculature, immune cells and nerves, upwards into the skin.
Wound cells rise from fascia
To trace the origins of cells in wounds, we developed a fate-mapping 
technique by transplanting chimeric skin and fascia grafts into living 
animals (Fig. 1a and Methods).
At 14 days post-wounding (dpw), 80.04 ± 3.443% (mean ± s.e.m.) of 
the labelled cells in the wound originated from fascia (Fig. 1b). Fascia-
derived cells filled the entire wound bordering the regenerated epi-
dermis and even the surrounding dermis, making up 35.46 ± 4.938% 
of the total labelled cells within a 0.2 mm radius (Fig. 1b, c). ACTA2+ 
myofibroblasts (81.63 ± 12.84%), nerve cells, endothelial cells and 
macrophages within wounds were predominantly of fascia origin 
(Fig. 1d, e). Independently, in vivo labelling of the fascia showed same 
results (Extended Data Fig. 1a, Methods). Labelled cells populated 
the wounds and surrounding dermis at 14 dpw, whereas in uninjured 
controls, labelled cells remained in the fascia (Extended Data Fig. 1b). 
Up to 56.71 ± 9.319% of fascia-derived cells in wounds expressed clas-
sical fibroblast markers (Extended Data Fig. 1c). Labelled monocytes 
(macrophages), lymphatics, endothelium and nerves also derived 
from fascia (Extended Data Fig. 1d). Collectively, our two independent 
fate-mapping approaches demonstrate that fascia is a major reservoir 
of fibroblasts, endothelial cells macrophages and peripheral nerves 
that populate wounds following injury.
Fascia fibroblasts dictate scar severity
We then analysed the scar-forming EPFs across dermal and fascia 
compartments by using a TdTomato-to-GFP replacement reporter12,13 
(En1cre;R26mTmG; see Methods). Fibroblasts were the predominant fascia 
cell type (71.1%), whereas dermis had a significantly lower fraction of 
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fibroblasts (56.4%, Extended Data Fig. 2a, b). Within this population, 
there were twice as many EPFs as En1-naive fibroblasts (ENFs) in the fas-
cia (61.2% and 31.8%, respectively). In dermis, there was a sixfold excess 
of EPFs (83.13% EPFs versus 12.78% ENFs; Extended Data Fig. 2c, d). 
Fascia was also enriched in regenerative cell types such as endothelial 
cells and lymphatics, whereas populations of macrophages and nerve 
cells were similar in both compartments (Extended Data Fig. 2e). Thus, 
a higher proportion of fibroblasts, endothelial cells and lymphatic 
cells and a lower EPF to ENF ratio distinguishes the fascia from dermis.
Two-photon microscopy revealed that fascia EPFs assemble in mon-
olayers of consecutive perpendicular sheets across the dorsal–ventral 
axis (Extended Data Fig. 2f, Supplementary Video 1). EPFs populate 
the entire back in topographic continua extending from the fascia 
and traversing the PC (Extended Data Fig. 2g, h Supplementary Video 
2). Regions where PC ended or where nerve bundles and blood ves-
sels traversed the PC also showed continuums of EPFs without clear 
boundaries (Extended Data Fig. 2i, j). To test whether fascia EPFs could 
access dermal layers upon injury, we generated superficial excisional 
wounds. Aggregates of EPFs rising into open wounds from fissures in 
the PC were observed after only 3 dpw (Extended Data Fig. 2k, Sup-
plementary Video 3). Collectively, our observations suggest that fascia 
EPFs easily traverse upwards into dermal layers during wounding and 
are unobstructed by the PC muscle.
The size of a scar increases with the depth of the injury16. We there-
fore investigated whether this correlation can be attributed to fascia 
by analysing the extent of fibroblast contributions from the fascia 
and dermis in deep versus superficial wounds. For this, we combined 
genetic lineage-tracing (En1cre;R26mTmG) with our anatomic fate-mapping 
chimeric grafts and inflicted superficial or deep injuries (Fig. 2a, Meth-
ods). Fourteen days post-wounding, mean wound size of deep injuries 
was 1.7 times that of superficial injuries (Fig. 2b, c). There were twice 
as many fascia EPFs in deep wounds, whereas the number of dermal 
EPFs remained constant in both conditions (Fig. 2d). The abundance of 
fascia EPFs in the wound directly correlated with wound size and thus 
scar severity, whereas dermal EPFs showed no such correlation (Fig. 2e, 
f). No crossing of EPFs between these compartments was observed in 
uninjured controls, indicating that the influx of fascia EPFs was trig-
gered by injury (Extended Data Fig. 3a, b).
Long-term tracing of fascia EPFs in wounds showed that they recede 
ten weeks after injury (Extended Data Fig. 3c). This desertion from 
mature scars occurred through an apoptosis-independent mechanism, 
indicated by a low rate of cell death (<5%) across earlier time points 
(Extended Data Fig. 3d, e).
We next sought to place fascia EPFs in the framework of known line-
age markers used to define different populations of wound fibroblasts 
such as CD24, CD34, DPP4, DLK1 and LY6A7,10,12. All markers were promi-
nent in fascia EPFs and were surprisingly downregulated upon entering 
the wound in our graft experiments (Extended Data Fig. 4). Flow cytom-
etry confirmed the higher expression of DPP4, ITGB1, LY6A and PDGFRα 
in fascia than in dermal fibroblasts (Extended Data Fig. 5a–c). Sorted 
fascia EPFs also revealed low cellular heterogeneity, with the population 

































































































































Fascia Skin Marker Merged
d
Fig. 1 | Fascia is a major cellular source for wounds. a, Generation of 6-mm 
diameter chimeric grafts with an inner 2-mm wound to determine 
contributions of dermis and fascia. b, Percentages of TdTomato+ or GFP+ cells 
from total labelled cells in the wound and wound margin. Data are 
mean ± s.e.m., n = 26 images from 4 biological replicates. One-way ANOVA, 
multiple comparison Tukey’s test, 95% confidence interval (CI). c, Wound 
showing skin- and fascia-derived cells at 14 dpw. d, e, Immunolabelling and 
contributions of myofibroblasts (ACTA2), nerves (TUBB3), blood vessels 
(PECAM1), monocytes or macrophages (MOMA-2) and lymphatic cells (LYVE1). 
Data are mean ± s.e.m.; n = 4 (LYVE1), 5 (ACTA2, TUBB3 and MOMA-2) or 8 
(PECAM1) images from 4 biological replicates. Unpaired two-tailed t-test, 95% 























































1,500 P = 0.0001
Deep SupercialInjury















































Fascia EPFs  DAPI Dermal EPFs  DAPI
Fig. 2 | Fascia EPFs dictate scar severity. a, Dermal versus fascia EPFs chimeric 
grafts. Chimeric grafts were prepared as in Fig. 1a, using the EPF reporter line 
En1cre;R26mTmG combined with Cre-negative littermate samples to trace EPFs in 
each compartment. b, Images showing fascia EPFs (left) or dermal EPFs (right) 
in wounds after a deep (top) or superficial injury (bottom). c, Wound size. Data 
are mean ± s.e.m.; n = 70 (deep) and 53 (superficial) images analysed from 5 
biological replicates. Unpaired, two-tailed t-test, 95% CI. d, Numbers of fascia 
and dermal EPFs. Data are mean ± s.e.m.; n = 27, 32, 27 and 22 images analysed 
from 5 biological replicates. Unpaired, two-tailed t-test, 95% CI. e, f, Plots of EPF 
fractions and wound size from fascia (e) and dermal EPFs (f). n = 57 (e) and 48 (f) 
images analysed from 5 biological replicates. Two-tailed Pearson’s R2 
correlation, 95% CI. Dotted lines delimit wounds. Scale bars, 200 μm.
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(72.8%) cells (Extended Data Fig. 5d). This broad marker convergence 
identifies fascia EPFs as the major source of wound fibroblasts.
Provisional matrix emerges from fascia matrix
We then looked at the fascia matrix itself. Second harmonic genera-
tion (SHG) signal and scanning electron micrographs (SEM) revealed 
profuse coiled collagen fibrils in the fascia, indicative of a relaxed and 
immature matrix (Fig. 3a, b). Fractal measurements13 of the fibre align-
ments showed a more condensed matrix configuration in fascia than 
the stretched and woven dermal matrix (Fig. 3c).
Given the immaturity of the fascia matrix, we checked whether it 
could work as a repository for scar tissue. We developed an incubation 
chamber that enabled live imaging of fascia biopsies over several days 
(Methods). Recording of SHG signals showed steering of the matrix 
at a rate of 11.4 μm h−1 (Fig. 3d, e, Supplementary Video 4). Assuming 
a similar rate in vivo, the fascia matrix could move about 2 mm in 7 
days, accounting for the dynamics of provisional matrix deposition 
in mammals.
To test whether fascia matrix steers into wounds in vivo, we devel-
oped a method to trace the fascia matrix in our chimeric grafts using 
NHS esters. (Fig. 3f, Methods). Streams of traced matrix from the fascia 
extended upwards and plugged the open wounds from 7 dpw (Fig. 3g, 
Extended Data Fig. 6a, b). Fascia-derived matrix covered 74.78 ± 12.94% 
of total collagen content in the wound (Extended Data Fig. 6c). Our data 
indicated that individual fascia matrix fibres were not being pulled; 
instead, pliable matrix was extended upwards to mould the wound. 
Advanced wound stages showed a decline in label in specific regions 
of the wound, suggesting an active remodelling process of the fascia-
derived matrix (Extended Data Fig. 6d–f, Supplementary Video 5).
We then tested whether dermal matrix could be steered by double 
labelling our chimeric grafts. Only the fascia matrix plugged deep injury 
wounds (Extended Data Fig. 6g–j), whereas dermal matrix remained 
immobile in deep and superficial injuries; the superficial injuries healed 
via de novo matrix deposition (Extended Data Fig. 6k, l).
To provide further evidence showing that fascia matrix migrates to 
open wounds, we labelled the fascia matrix in situ before injury (Fig. 3h, 
i, Methods). Labelled matrix made up most of the wound provisional 
matrix (Fig. 3j), which underwent remodelling during the first two 
weeks following injury (Extended Data Fig. 7a, b). Fractal measurements 
showed that fascia fibre interfaces expanded by 3 dpw, changing from 
a parallel sheet arrangement to a highly porous plug. This expansion 
was followed by contraction into thicker and more complex mature 
scar matrix architecture (Extended Data Fig. 7c–e). Surprisingly, traced 
matrix was also present in the eschar. Activated platelets infiltrated 
and clustered within fascia fibres before eschar formation (Extended 
Data Fig. 7f), indicating that the coagulation cascade occurs in parallel 
with fascia matrix steering.
EPFs steer fascia matrix into wounds
To test whether matrix steering from fascia is caused by EPFs, we 
blocked fascia by implanting an impermeable dual surface expanded 
polytetrafluoroethylene (ePTFE) membrane17 between the fascia and 
the PC in wounds of En1cre;R26VT2/GK3 mice (Fig. 4a, Methods). Surpris-
ingly, wounds with implants remained completely open whereas sham 
controls closed within 21 days (Fig. 4b). After two months, EPFs trailed 
from the wound margins and under the membrane without generating 
scars (Fig. 4c, Extended Data Fig. 8a). Implants produced a transient 
inflammation that resolved even when the wound remained open. Two-
month-old wounds with implants showed normal leukocyte and pro- 
and anti-inflammatory interleukins levels (Extended Data Fig. 8b–i), 
consistent with the clinical use of ePTFE as immunologically inert 
membranes. The coagulation cascade also was unaltered at the bor-
der between the dermis and the membrane (Extended Data Fig. 8j, k). 
These results indicate that the lack of scarring with ePTFE membranes 
does not reflect chronic inflammation or poor clotting, but rather a 
blockade of fascia steering mediated by the fascia fibroblasts. These 
findings further support the notion that scar tissue is mostly derived 
from the fascia, since dermal EPFs or dermal matrix are unable to repair 
wounds in the absence of fascia movements.
We next investigated whether mechanical separation between dermis 
and fascia alone, without barrier implants, would affect matrix steer-
ing and scar formation. To address this question, we performed full 
excisional wounds in wild-type mice and physically released the fascia 
below the PC around the wound (Fig. 4d). Wound closure from released-
fascia wounds was significantly delayed, and wounds remained open 
early on, similarly to those documented following membrane implan-
tations (Fig. 4e, f).
To definitively link fascia EPFs to matrix steering, we genetically 
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Fig. 3 | Fascia matrix steers into wounds. a, SHG (a) and SEM images (b) of 
fascia (left) and dermis (right) showing matrix arrangements, representative 
images of 3 biological replicates. c, Fractal dimension and lacunarity values 
from SHG images. n = 6 (dermis) and 3 (fascia) images analysed from 3 
biological replicates. Unpaired two-tailed t-test, 95% CI. d, Time-lapse images 
of fascia in culture at time 0 (left) and 30 h (right). Representative video from at 
least three independent experiments. Autof., autofluorescence. e, Contraction 
rate from the SHG and autofluorescence. Data derived from Supplementary 
Video 4. f, Fascia matrix labelling with AF647 NHS ester in chimeric grafts. 
TdTomato and GFP reporter lines biopsies were used for the chimeric grafts as 
before. Only the matrix of the GFP-positive fascia compartment was labelled 
before transplantation. g, Images at 7 dpw showing fascia matrix covering the 
wound. Representative image of at least three biological replicates. h, In situ 
fascia matrix-tracing experiment using FITC NHS ester. Subcutaneous 
injections of FITC NHS ester were performed 4 and 2 days before wounding in 
the back-skin of wild-type mice to label the fascia matrix. i, Uninjured controls 
showing specificity of the labelling in fascia. Representative sample of at least 
three biological replicates. j, Images from 7 dpw showing fascia matrix 
covering the wound area. Representative samples of at least three biological 
replicates. Arrowheads indicate the original injury. Broken lines delimit dermis 
(g and j) or PC (i). Scale bars, 30 μm (a, b), 500 μm (d, g, i, j), and 100 μm (g, j 
magnified insets).
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transgenic line that expresses the diphtheria toxin receptor (DTR) in a 
Cre-dependent manner (R26iDTR), enabling us to deplete cells expressing 
Cre recombinase upon exposure to diphtheria toxin (DT). We thus gen-
erated Cre-expressing adeno-associated viral particles (AAV6-Cre) and 
injected them into the fascia of R26iDTR pups underneath freshly made full 
excisional wounds (Fig. 4g). Scar size from AAV6-Cre transduced mice 
treated with DT were significantly smaller those from controls (Fig. 4h, i).
Second, we used En1cre;R26iDTR double transgenic mice, in which 
DTR expression is restricted to EPFs, making them susceptible to 
DT-mediated ablation. We corroborated the ablation of fascia EPFs in 
cultured biopsies 6 days after acute exposure to DT for 1 h. Effective 
dose of DT prevented the normal increase in collagen fibre density 
observed in control samples and decreased the cell density by 2.5 times 
(Extended Data Fig. 9a–c). Live imaging showed absence of any matrix 
steering after DT exposure (Extended Data Fig. 9d, e, Supplementary 
Video 6), confirming that fascia EPFs are essential for matrix steering.
Next, we created chimeric grafts using dermis from wild-type mice 
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Fig. 4 | Fascia EPFs steer scar primordium into wounds. a, 8-mm diameter 
ePTFE membranes were implanted between the skin and fascia in fresh 6-mm 
diameter wounds to block fascia steering. b, ePTFE-implanted or sham wound 
closure (left) determined from photographs (right) at specified time points. 
Individual values, n = 3 biological replicates. Unpaired two-tailed t-test, 95% CI. 
c, Sham (left) or ePTFE-implanted (right) wounds at 63 dpw. Trichrome staining 
(top) and collagen immunolabelling (middle). Magnifications (1, 2 (bottom)) 
show multiclonal dermal EPFs. Representative images from 3 biological 
replicates. d, Fascia tissue around fresh 5-mm diameter wounds was 
mechanically separated from the skin above using a metal paddle. e, Fascia-
released or control wound closure (left) determined from photographs (right) 
at specified time points. Individual values, n = 8 (0–3 dpw), 6 (5 dpw), 4 (7 dpw) 
and 2 (10 dpw) images from 8 biological replicates. Unpaired two-tailed t-test, 
95% CI. f, Trichrome-stained wounds at 3, 5 and 7 dpw from control or fascia-
released wounds. Representative images from 8 biological replicates. g, Fascia 
cell depletion in R26iDTR neonates. h, Fluorescence image (left) and trichrome-
stained wounds at 7 dpw in GFP- (middle) or Cre-transduced (right) fascia. 
Representative images from 3 biological replicates. i, Scar-length 
measurements. Data are mean ± s.e.m.; n = 4 and 8 sections from 3 biological 
replicates. Unpaired two-tailed t-test, 95% CI. j, Depletion of fascia EPFs in 
chimeric grafts with fascia matrix labelling. k, Immunolabelling for collagens, 
and fascia matrix in control (left) or DT-treated (right) grafts. Representative 
images from 3 biological replicates. l, Matrix-labelling coverage. Data are 
mean ± s.e.m.; n = 6 sections from 3 biological replicates. Unpaired two-tailed  
t-test, 95% CI. Dashed lines delimit the implant. Dotted lines delimit the wound. 
Arrowheads indicate the original injury. Arrow indicates remaining labelled 
fascia matrix in DT-treated grafts. Scale bars, 50 μm (c (1 and 2)), 200 μm (h), 
and 500 μm (c (main image), f, h, k).
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and labelled the matrix before transplantation (Fig. 4j). Ablation of 
fascia EPFs prevented matrix steering into the wound (Fig. 4k, l) and 
instead labelled matrix remained in the fascia layer below. Together, 
our data demonstrate that fascia resident EPFs actively steer matrix 
to seal open wounds.
To check whether fibroblast proliferation preceded and was needed 
for matrix steering, we analysed the proliferation rate in our matrix-
tracing experiments. Expansion of the fascia gel beneath the wound 
occurred during the first days after injury, whereas cell proliferation 
peaked after one week (Extended Data Fig. 10a–c), indicating that pro-
liferation is not required for matrix steering. Furthermore, treatment 
with a proliferation inhibitor had no effect on fascia matrix steering 
in vitro (Extended Data Fig. 9f–k, Supplementary Video 7). Our results 
demonstrate that fascia matrix works as an expanding sealant that 
quickly clogs deep wounds independently of cell proliferation.
Fascia and keloid share marker signatures
Similar to mouse fascia matrix, human keloids present poorly struc-
tured and densely packed collagen fibres18. This motivated us to inves-
tigate the presence of fascia fibroblasts in keloid tissue. We screened 
for markers present in keloids and compared them with healthy dermis 
and the connective tissue in the subcutaneous space (fascia) of human 
skin across multiple anatomic locations (Fig. 5a, b). FAP and DPP4 were 
highly expressed in both fascia and keloids, with low expression in der-
mis. The fascia-restricted protein NOV was also prominently expressed 
in both human and mouse fascia, as well as in human keloids and mouse 
scars (Fig. 5c–g). This preservation of fascia markers across mouse 
and human fascia and keloid scars suggests a common fascia origin 
for most human cutaneous scars.
Discussion
Current models of wound healing propose that dermal fibroblasts 
migrate into wounds and locally deposit matrix de novo onto the 
granulation tissue provided by the coagulation cascade. This provi-
sional matrix is then remodelled into a mature scar. On the basis of our 
findings in this study, we propose a revised model (Fig. 6) in which, in 
deep injuries, fascia fibroblasts pilot their local composite matrix into 
wounds that, in coordination with the coagulation cascade, form the 
provisional matrix. Thus, instead of de novo matrix deposition by der-
mal fibroblasts, a ‘scar primordium’ is steered by the fascia fibroblasts. 
Thus, fascia serves as an external repository, or externum repono, of 
scar-forming provisional matrix, which represents an efficient mecha-
nism to quickly seal large open wounds. Previous studies have shown 
that the matrix undergoes movement during early development and 
organ morphogenesis19–22. To our knowledge, the extent and magnitude 
of matrix movements that we document here have not been observed 
during injury or regenerative settings. Cultured dermal fibroblasts have 
been shown to pull and reorient individual collagen or fibronectin fibres 
locally in cultured plates and in 3D in vitro assays23,24. However, our find-
ings reveal highly dynamic and large-scale movements of composite 
tissue matrix during injury that are mediated exclusively by specialized 
fibroblasts of the fascia.
Our findings on the contribution of fascia to large scars and its block-
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Fig. 5 | Marker signature in keloids and fascia. a, b, Macroscopic images and 
trichrome staining of human back (a) and abdominal (b) skin showing fascia 
layers embedded in subcutaneous tissue. Arrows indicate the fascia. 
Representative images from 4 independent samples. c, Immunolabelling for 
DPP4, CD44 and FAP, and NOV and ACTA2 in fascia, dermis and keloids of 
human back skin. d, Relative fluorescence intensity (RFI) in c, normalized to the 
dermis. Data are mean ± s.e.m.; n = 4 images analysed from 4 biological 
replicates. One-way ANOVA with Tukey’s test, 95% CI. e, f, Immunostaining for 
NOV in En1cre;R26mTmG 14 dpw scars. g, Relative fluorescence intensity in f, 
normalized to the dermis. Data are mean ± s.e.m.; n = 6 images of 3 biological 
replicates. One-way ANOVA, Tukey’s test, 95% CI. Dotted and broken lines 
delimit scar and fascia, respectively. Scale bars, 2 mm (a, b), 50 μm (c) and 
200 μm (e, f).
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and excessive scarring in the skin, such as in diabetic and ulcerative 
wounds, as well as in hypertrophic and particularly keloid scars, might 
all be attributed to fascia. Indeed, the subcutaneous fascia varies widely 
according to species, sex, age and anatomic skin location25. In some 
mammals, the superficial fascia is loose, whereas in scar-prone species 
such as human, dog and horse, the superficial fascia is thicker. Human 
fascia further varies in thickness in different regions of the body26. 
For example, the lower chest, back, thigh and arm have much thicker 
and multi-layered membranous sheets, and it is these anatomic sites 
that are prone to form hypertrophic and keloid scars27. Understand-
ing the topographic anatomy of the fascia layer may help explain scar 
phenotypes and severities, including the occurrences of hypertrophic 
and keloid scars.
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Fig. 6 | Revised wound healing model. Superficial injuries heal by the classical 
fibroblast migration and de novo matrix deposition process. In response to a 
deep injury, fascia fibroblasts steer their surrounding tissue into wounds. 
Fascia-derived macrophages, endothelial and peripheral nerves rapidly clog 
the open wound. In coordination with the platelet response, the fascia matrix 




All mouse strains (C57BL/6J, En1cre, R26VT2/GK3, R26mTmG, R26iDTR, Rag2−/− and 
Fox Chase SCID) were obtained from either Jackson laboratories, Charles 
River or generated at the Stanford University Research Animal Facility 
as described previously12. Animals were housed at the Helmholtz Center 
Animal Facility. Cages were maintained at constant temperature and 
humidity with a 12-h light cycle. Animals were supplied with food and 
water ad libitum. All animal experiments were reviewed and approved 
by the Government of Upper Bavaria and registered under the pro-
jects 55.2-1-54-2532-16-61 and 55.2-2532-02-19-23 and conducted under 
strict governmental and international guidelines. This study is com-
pliant with all relevant ethical regulations regarding animal research. 
Unless specified, 8-to-10-week-old adult mice were used for the ani-
mal experiments. Both male and female mice were used. Cre-positive 
(Cre+) animals from double-transgenic reporter mice were identified 
by detection of relevant fluorescence in the dorsal dermis. Genotyping 
was performed to distinguish mouse lines containing a 200-base pair 
(bp) cre fragment (cre+/−) from the wild-type (cre−/−). Genomic DNA from 
the ear-clips was extracted using QuickExtract DNA extraction solu-
tion (Epicentre) following the manufacturer's guidelines. DNA extract 
(1 μl) was added to each 24 μl PCR. The reaction mixture was set up using 
Taq PCR core kit (Qiagen) containing 1× coral buffer, 10mM dNTPs, 
0.625 units Taq polymerase, 0.5 μM forward primer ‘Cre_genotype_4F’ 
5′-ATTGCTGTCACTTGGTCGTGGC-3′ (Sigma) and 0.5 μM reverse primer 
‘Cre_genotype_4R’ 5′-GGAAAATGCTTCTGTCCGTTTGC-3′ (Sigma). PCRs 
were performed with initial denaturation for 10 min at 94 °C, amplifica-
tion for 30 cycles (denaturation for 30 s at 94 °C, hybridization for 30 s 
at 56 °C, and elongation for 30 s at 72 °C) and final elongation for 8 min 
at 72 °C, and then cooled to 4 °C. In every experiment, negative controls 
(non-template and extraction) and positive controls were included. The 
reactions were carried out in an Eppendorf master cycler. Reactions 
were analysed by gel electrophoresis.
Human skin samples
Fresh human skin and scar biopsies, from various anatomic locations, 
were collected from donors between 18–65 years of age, through the 
Section of Plastic and Aesthetic Surgery, Red Cross Hospital Munich (refer-
ence number 2018-157), and by the Department of Dermatology and Aller-
gology, Klinikum rechts der Isar Technical University Munich (reference 
number 85/18S). Informed consent was obtained from all subjects before 
skin biopsies. Upon collection, these samples were directly processed for 
tissue culture or fixed with PFA and then processed for cryosection or 
paraffin section followed by histological or immunofluorescent analyses.
Fascia in vitro culture
Two in vitro systems were used. To visualize the changes in matrix 
architecture in real time, 2-mm-diameter biopsies were excised from 
P0 C57BL/6J neonates and processed for live imaging (SCAD assay, 
Patent Application no. PLA17A13). To determine the effectiveness of 
the DT treatment, muscle and fascia were manually separated from the 
rest of the skin in the chimeric grafts experiments and incubated with 
DT at different concentrations for 1 h at ambient temperature. Next, 
samples were washed with PBS and incubated in DMEM/F12 (Thermo 
Fisher) supplemented with 10% serum (Thermo Fisher), 1% penicillin–
streptavidin (Thermo Fisher), 1% GlutaMAX (Thermo Fisher) and 1% 
non-essential amino acids solution (Thermo Fisher) in a 37 °C, 5% CO2 
incubator. Medium was routinely exchanged every other day. Samples 
were fixed at day 6 of culture with 2% paraformaldehyde and processed 
for histology.
Histology
Tissue samples were fixed overnight with 2% paraformaldehyde in PBS 
at 4 °C. Samples were rinsed three times with PBS, embedded in optimal 
cutting temperature (OCT, Sakura Finetek) and flash-frozen on dry 
ice. Six-micrometre sections were made in a Cryostar NX70 cryostat 
(Thermo fisher). Masson’s trichrome staining was performed with a 
Sigma-Aldrich trichrome stain kit, according to the manufacturer's 
guidelines. For immunolabelling, sections were air-dried for 5 min 
and fixed with −20 °C-chilled acetone for 20 min. Sections were rinsed 
three times with PBS and blocked for 1 h at room temperature with 10% 
serum in PBS. Then, the sections were incubated with primary antibody 
in blocking solution for 3 h at ambient temperature. Sections were then 
rinsed three times with PBS and incubated with secondary antibody 
in blocking solution for 60 min at ambient temperature. Finally, sec-
tions were rinsed three times in PBS and mounted with fluorescent 
mounting media with 4,6-diamidino-2-phenylindole (DAPI). Primary 
antibodies used: goat-anti-ACTA2(αSMA) (1:50, Abcam), rabbit-anti-
TUBB3 (1:100, Abcam), rat-anti-THY1(CD90) (1:100, Abcam), rat-anti-
CD24 (1:50, BD biosciences), rabbit-anti-DPP4(CD26) (1:150, Abcam), 
rabbit-anti-PECAM1 (1:10, Abcam), rat-anti-CD34 (1:100, Abcam), 
rabbit-anti-collagen I (1:150, Rockland), rabbit-anti-collagen III (1:150, 
Abcam), rabbit-anti-collagen VI (1:150, Abcam), rabbit-anti-DLK1 (1:200, 
Abcam), rat-anti-ERTR7 (1:200, Abcam), rat-anti-F4/80 (1:400, Abcam), 
rabbit-anti-LYVE1 (1:100, Abcam), rat-anti-MOMA2 (1:100, Abcam), 
goat-anti-PDGFRα (1:50, R & D systems), rat-anti-LY6A(Sca1) (1:150, 
Biolegend), rat-anti-CD44 (1:100, Abcam), rabbit-anti-NOV/CCN3 (1:20, 
Elabscience), sheep-anti-FAP (1:100, R&D systems), rat-anti-IL12 (1:50, 
Biolegend), rat-anti-IL4 (1:50, Biolegend), rat-anti-CD19 (1:20, BD bio-
sciences), hamster-anti-CD3e (1:100, Biolegend), rat-anti-NCR1 (1:20, 
Biolegend) and rat-anti-LY6G (1:100, Abcam). PacificBlue-, Alexa Fluor 
488-, Alexa Fluor 568- or Alexa Fluor 647-conjugated antibodies (1:500, 
Life technologies) against suitable species were used as secondary 
antibodies.
Microscopy
Histological sections were imaged using a using a ZEISS AxioImager.
Z2m (Carl Zeiss). For whole-mount 3D imaging of wounds, fixed samples 
were embedded in 35-mm glass bottom dishes (Ibidi) with low-melting 
point agarose (Biozym) and left to solidify for 30 min. Imaging was per-
formed using a Leica SP8 multi photon microscope (Leica, Germany). 
For live imaging of fascia cultures, samples were embedded as just 
above. Attention was paid to mount the samples with the fascia fac-
ing up towards the objective. Imaging medium (DMEM/F-12; SiR-DNA 
1:1,000) was then added. Time-lapse imaging was performed over 20 h 
under the multi-photon microscope. A modified incubation system, 
with heating and gas control (ibidi, catalogue nos. 10915 and 11922), was 
used to guarantee physiologic and stable conditions during imaging. 
Temperature control was set to 35 °C with 5% CO2-supplemented air. 
Second harmonic generation signal and green auto-fluorescence as 
a reference were recorded every hour. 3D and 4D data was processed 
with Imaris 9.1.0 (Bitplane) and ImageJ (1.52i). Contrast and brightness 
were adjusted for better visibility.
Image analysis
Histological images were analysed using ImageJ. For quantification of 
labelled cells in our fate mapping experiments, we manually defined 
the wound, surrounding dermis, and adjacent fascia areas. We defined 
the wound as the area flanked by the near hair follicles on both sides, 
extending from the base of the epidermis down to the level of the hair 
follicles bulges. Surrounding dermis area was defined as the 200 μm 
immediately adjacent to the wound on both sides. Fascia area was 
defined as the tissue immediately below the wound. The number of 
labelled cells in each area was determined by quantifying the parti-
cles that were double-positive for DAPI and for the desired label (for 
example, DiI or GFP) channels. The coverage of the labelled matrix 
in the wound area was determined by quantifying the area that was 
double-positive for the labelled matrix and the collagen I-, III- and VI-
staining signal. Cell density of En1cre;R26iDTR cultures treated with DT was 
Article
quantified by dividing the total cells (DAPI) by the matrix area (collagen 
I, III and VI), Collagens density was calculated as the collagens area cov-
erage of the entire section area. Matrix movements in live-imaged cul-
tures were determined by tracking the length of the two furthest points 
along the sample in both the SHG and auto-fluorescence channels. 
Length measurements were normalized to the original length at time 0. 
Wound size was normalized for each time point using the original area 
at day 0. Scar length was quantified from randomly selected sections 
taken from the middle of the scar using the two flanking hair follicles 
as a reference. RFI was calculated by measuring the mean grey value 
and normalize to the dermis images. Fractal analysis was performed 
using the ImageJ plug-in ‘FracLac’29 (FracLac2015Sep090313a9390) 
using the same settings and preprocessing as previously described13.
DiI labelling of fascia in animals
Two 5-mm-diameter full-thickness excisional wounds were created 
on the back of 8- to 10-week-old C57BL6/J mice with a biopsy punch. 
Lipophilic Vybrant DiI dye (Life technologies, V22885) (10–20 μl) was 
injected into the exposed fascia directly above the dorsal muscles. 
Wounded tissue was harvested 14 dpw and processed for histology 
and imaging by fluorescence microscopy.
Chimeric skin transplantation
Full-thickness 6-mm-diameter biopsies were collected from the back-
skin of either R26mTmG, R26VT2/GK3, En1cre;R26mTmG, En1cre;R26iDTR or C57BL6/J 
adult mice. Using the PC muscle layer as an anatomical reference, the 
fascia together with the muscle layer were carefully separated from 
the dermis and epidermis using Dumont no. 5 forceps (Fine Science 
Tools) and a 26G needle under the fluorescent stereomicroscope 
(M205 FA, Leica). EPFs from fascia + muscle samples of En1cre;R26iDTR 
mice were ablated by incubation with 20 μg ml−1 of diphtheria toxin 
(Sigma-Aldrich, D0564) or only DMEM/F12 as vehicle for 1 h at ambient 
temperature followed by 3 washing steps with PBS. At this point, the 
matrix samples were labelled by incubation with 100 μM Alexa Fluor 
NHS Ester (Life Technologies, A20006) or Pacific Blue succinimidyl 
ester (Thermo Fisher, P10163) in PBS for 1 h at ambient temperature 
followed by 3 washing steps with PBS. Chimeras were made by placing 
the epidermis + dermis portion of a mouse strain on top of the mus-
cle + fascia of another strain and left to rest for 20 min at 4 °C inside a 
35-mm culture dish with 2 ml of DMEM/F12. Special attention was paid 
on preserving the original order of the different layers (top to bottom: 
epidermis > dermis > muscle > fascia). Then, a 2 mm ‘deep’ full thickness 
was excised from the chimeric graft using a biopsy punch in the middle 
of the biopsy. To create ‘superficial’ wounds, the 2-mm excision was 
done only in the epidermis + dermis half before reconstitution with 
the bottom part. ‘Wounded’ chimeric grafts were then transplanted 
into freshly-made 4-mm-diameter full-thickness excisional wounds 
in the back of either RAG2−/− or Fox Chase SCID immunodeficient 8- to 
10-week-old mice. Precautions were taken to clean out the host blood 
from the fresh wound before the transplant and to leave the graft to 
dry for at least 20 min before ending the anaesthesia, to increase the 
transplantation success. To prevent mice from removing the graft, a 
transparent dressing (Tegaderm, 3M) was placed on top of the grafts.
In situ matrix tracing and EdU pulses
Eight- to ten-week-old C57BL6/J mice received subcutaneous 20-μl injec-
tions of 10 mg ml−1 FITC NHS ester in physiological saline with 0.1 M sodium 
bicarbonate pH9 (46409, Life technologies) four and two days before 
wounding. At 2, 6 or 13 dpw, mice received 200 μl intraperitoneal injections 
of 1 mg ml−1 EdU in PBS. Samples were collected 24 h after the EdU pulse 
and processed for cryosection and imaging by fluorescence microscopy.
Flow cytometry
Fascia and dermis were physically separated from the back-
skin of C57BL6/J or En1cre;R26mTmG mice under the fluorescence 
stereomicroscope as before. Harvested tissue was minced with surgical 
scissors and digested with an enzymatic cocktail containing 1 mg ml−1 
collagenase IV, 0.5 mg ml−1 hyaluronidase, and 25 U ml−1 DNase I (Sigma-
Aldrich) at 37 °C for 30 min. The resulted single cell suspension was 
filtered and incubated with conjugated/unconjugated primary antibod-
ies (dilution 1:200) at 4 °C for 30 min, followed by an incubation with a 
suitable secondary antibody when needed at 4 °C for 30 min. Cells were 
washed and stained with Sytox blue dye (dilution 1:1,000. Life technolo-
gies, S34857) for dead cell exclusion. Cells were subjected to flow cyto-
metric analysis using a FACSAria III (BD Bioscience). Fibroblasts were 
gated as the lineage negative (Lin−) fraction not expressing the PTPRC, 
PECAM1, LY76, LYVE-1, or EPCAM markers. Primary antibodies used: 
anti-DLK1 (Abcam), anti-CD9 (Santa Cruz), anti-NGFR (Miltenyi), anti-
F4/80 (Abcam), AlexaFluor790-anti-NG2 (Santa Cruz), FITC-anti-DPP4 
(eBioscience), PerCP-eFluor710-anti-ITGB1 (eBioscience), anti-CD34 
(Abcam), PerCP-Cy5.5-anti-CD24 (eBioscience), APC-Fire750-anti-CD34 
(Biolegend), APC-anti-ITGA7 (R&D systems), PerCP-Cy5.5-anti-LY6A 
(eBioscience), PE-Vio770-anti-PDGFRα (Miltenyi), PerCP-Vio700-anti-
CD146 (Miltenyi), APC-anti-PECAM1 (eBioscience), eFluor660-anti-
LYVE1 (Thermo fisher), APC-LY76(TER119), APC-anti-EPCAM(CD326) 
and APC-anti-PTPRC. Secondary antibodies used: Alexa Fluor 488 goat 
anti-rabbit (Life technologies) and AlexaFluor568 goat anti-rat (Life 
technologies).
Scanning electron microscopy
Skin biopsies of adult C57BL6/J mice were collected, and the fascia 
was manually separated as before. Samples were then fixed overnight 
with paraformaldehyde and glutaraldehyde, 3% each, in 0.1% sodium 
cacodylate buffer pH 7.4 (Electron Microscopy Sciences). Samples were 
dehydrated in gradual ethanol and dried by the critical-point method, 
using CO2 as the transitional fluid (Polaron Critical Point Dryer CPC 
E3000; Quorum Technologies) and observed by scanning electron 
microscopy ( JSM 6300F; JEOL).
ePTFE membrane implants
These membranes are routinely used in the clinic to circumvent 
post-operative adhesions after laparoscopic ventral incisional hernia 
repairs17. Two 6-mm-diameter full-thickness excisional wounds were 
created with a biopsy punch on the back of 8-week-old En1cre;R26VT2/GK3 or 
C57BL6/J mice. Sterile 8-mm-diameter ePTFE impermeable membranes 
(Dualmesh, GORE) were implanted between the surrounding skin and 
the fascia underneath, to cover the open wound on the right side. For 
this, the surrounding skin was loosen using Dumont no. 5 forceps and 
spatula (10090-13, Fine Science Tools). The dual-surface membrane was 
implanted with the attaching face facing out, so to promote dermal cell 
attachment, while the smooth surface was in direct contact with the 
fascia. The left sham control wound underwent the same procedure 
without implanting any membrane. Each wound was photographed at 
indicated time points, and wound areas were measured using ImageJ. 
Wound sizes at any given time point after wounding were expressed as 
percentage of initial (day 0) wound area. At 7 or 63 dpw, samples were 
collected and processed for histology.
Released fascia injury in adult mice
Two 5-mm-diameter full-thickness excisional wounds were created 
with a biopsy punch on the back of 8-week old male C57BL6/J mice. 
The skin around the wound on the left side was separated from the 
underneath skeletal muscle using a sterilized gold-plated 3 × 5 mm 
genepaddles (Harvard Apparatus, 45-0122) to release the fascia layer. 
The right wound served as a control. Each wound was digitally pho-
tographed at indicated time points, and wound areas were measured 
using Photoshop (Adobe Systems). Wound sizes at any given time point 
after wounding were expressed as percentage of initial (day 0) wound 
area. The harvested tissue at the indicated time points was processed 
for cryosection and Masson’s trichrome staining for histology.
Viral particle production
AAV6 expressing GFP or Cre recombinase were produced by trans-
fecting the AAVpro 293T Cell Line (Takara Bio, 632273) with pAAV-U6-
sgRNA-CMV-GFP (Addgene, 8545142) or pAAV-CRE Recombinase vector 
(Takara Bio, 6654), pRC6 and pHelper plasmids procured from AAVpro 
Helper Free System (Takara Bio, 6651). Transfection was performed 
with PEI transfection reagent and viruses were harvested 72 h later 
and purified with an AAVpro purification kit (Takara Bio, 6666) and 
titre was calculated using real-time PCR.
Fascia cells ablation with AAV6-Cre viral particles and DT 
treatment in pups
Two 3-mm-diameter full-thickness excisional wounds were created with 
a biopsy punch on the back of postnatal day 11 (P11) R26iDTR mice. Twenty 
microlitres of Cre-expressing AAV6-Cre or control AAV6-eGFP at viral 
titre of 5 × 1011 ml−1 were injected subcutaneously at the area between 
the two wounds. DT solution at 1 ng μl−1 in PBS was intraperitoneally 
injected to each mouse once per day for 7 days at the dosage of 5 ng g−1. 
Tissue was collected seven days after wounding.
Statistics
Statistical analyses were performed using GraphPad Prism software 
(v.6.0, GraphPad). Statistical test and P values are specified in the figure 
legends and in the corresponding plots. For simplicity, P values below 
0.0001 were stated as equal to 0.0001.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
Source Data for Figs. 1–5 and Extended Data Figs. 1–10 are provided with 
the paper. Additional information is available from the corresponding 
author on reasonable request. 
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Extended Data Fig. 1 | Fate mapping of fascia cells with DiI. a, DiI labelling of 
fascia cells. b, Histology showing DiI+ cells in uninjured controls (left) and at 
14 dpw (right). Representative images of five biological replicates.  
c, Immunolabelling (top) and fractions (bottom) of DiI-positive cells 
expressing mesenchymal/fibroblast markers ITGB1, ER-TR7, THY1 and 
PDGFRα. Data are mean ± s.e.m.; n = 4 (5 in ITGB1) images analysed from 3 
biological replicates. d, Immunolabelling (top) and fractions (bottom) of DiI-
positive monocytes/macrophages (MOMA-2), lymphatic cells (LYVE1), 
endothelial cells (PECAM1) and nerve cells (TUBB3). Data are mean ± s.e.m.; 
n = 5 images analysed from 3 biological replicates. Lines delimit PC. The dotted 
line delimits the wound. Scale bars, 200 μm.
Extended Data Fig. 2 | Fascia EPFs traverse PC. a, Gating strategy for 
fibroblasts analysis. b, Percentages of fibroblasts (Lin−) and lineage-positive 
cells in fascia and dermis. Data are mean ± s.e.m.; n = 4 independent 
experiments. Unpaired two-tailed t-test, 95% CI. c, Scatter plots of EPFs 
(GFP+Lin−) and ENFs (TdTomato+Lin−) in fascia and dermis. Representative plots 
of three independent experiments. d, EPF and ENF fractions in fascia and 
dermis. Data are mean ± s.e.m.; n = 4 independent experiments. Two-way 
ANOVA, multiple comparison Tukey’s test, 95% CI. e, Endothelial cell (PECAM1+), 
lymphatic cell (LYVE1+), macrophages (F4/80+) and nerve cell (NGFR+) fractions 
in fascia and dermis. Data are mean ± s.e.m.; n = 3 biological replicates. Two-way 
ANOVA, multiple comparison Tukey’s test, 95% CI. f–k, Representative images 
of 3D-rendered En1cre;R26mTmG or En1cre;R26VT2/Gk3 back skin fascia from at least 
three biological replicates. f, Lateral view (left) and cross-sections (right) of 
adult fascia. g, Top view (ventral side up) of neonate back skin. h, Top side view 
(top) and lateral cross-section (bottom) at the forelimb junction showing EPF 
traversing the PC. i, Top view at a muscle breach showing EPFs in both locations. 
j, Top view at a muscle opening where nerves pass through and polyclones of 
EPFs reside. k, Top view (top, epidermis side up) and lateral cross-section 
(bottom) of an adult superficial wound (3 dpw). Brocken lines delimit PC. 
Dotted lines delimit the epidermis. Scale bars, 1,500 μm (g), 100 μm (f, i, j) and 
500 μm (k); v, vessels; nb, nerve bundles.
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Extended Data Fig. 3 | Fascia EPFs maintain position in steady conditions 
and recede from wounds over time. a, Dermal versus fascia EPFs chimeras in 
uninjured conditions. b, Fascia (left) or dermal (right) EPFs-traced chimeras. 
Representative images of 3 biological replicates. c, Scars at 70 dpw from deep 
injuries of fascia EPF-traced chimeras immunolabelled for DPP4. 
Representative images of 3 biological replicates. d, Cleaved CASP3 expression 
in wounds from fascia (left) or dermal (right) EPF-traced chimeras from deep 
(top) or superficial (bottom) injuries at 14 dpw. e, Fractions of fascia or dermal 
EPFs in the wound, dermis or fascia control regions positive for cleaved CASP3. 
Data are mean ± s.e.m.; n = 6 and 5 (fascia and dermal EPF, respectively) images 
analysed from 5 biological replicates. Lines delimit the border between fascia 
and dermis. Dotted lines delimit the wound or scar. Scale bars, 200 μm.
Extended Data Fig. 4 | Fascia EPFs express wound fibroblast markers.  
a, Dermal versus fascia EPF-traced chimeras with two injury conditions.  
b–f, Representative immunolabelling for the fibroblast markers DPP4 (b), DLK1 
(c), CD24 (d), CD34 (e) and LY6A (f) from 4 biological replicates. g, Areas 
analysed (top) for marker-positive EPF quantification (bottom). Data are 
mean ± s.e.m.; n = 4 (DPP4 in dermal EPFs), 5 (all markers in dermal EPFs with the 
exception of DPP4 and all markers in fascia EPFs with the exception of DLK1, 
CD34 and LY6A), 6 (DLK1 in fascia EPFs), 7 (CD34 in fascia EPFs) or 11 (LY6A in 
fascia EPFs) images analysed from 4 biological replicates. One-way ANOVA, 
multiple comparison Tukey’s test, 95% CI. Dotted lines delimit the wound bed. 
Scale bars, 200 μm.
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Extended Data Fig. 5 | Differential expression of classical markers on fascia 
and dermal fibroblasts. a, Gating strategy for fibroblast (Lin−) cytometry.  
b, Histogram plots of fibroblast-marker expression in fascia or dermis derived 
fibroblasts from three biological replicates. c, Fraction of marker-positive cells 
from total fibroblast population. Data are mean ± s.e.m.; n = 3 biological 
replicates. Unpaired two-tailed t-test, 95% CI. d, Gating strategy for fascia EPF 
(Lin− GFP+) sorting and detection of LY6A, PDGFR1, DPP4 and ITGB1 expression. 
Representative plots of three biological replicates.
Extended Data Fig. 6 | Fascia but not dermal matrix steers into wounds.  
a, Matrix tracing in chimeric grafts. b, Grafts at 7 dpw immunolabelled for 
collagen I, III and VI. Representative image of three biological replicates.  
c, Label coverage fraction from total collagens in the wound at defined time 
points. Data are mean ± s.e.m.; n = 4 (7 dpw) and 9 (14 dpw) sections analysed 
from 3 biological replicates. Unpaired two-tailed t-test, 95% CI. d, Wounds at 
14 dpw immunolabelled for collagens. Representative images of three 
biological replicates. e–f, Higher magnification of the insets in d. g, h, Double 
matrix tracing in deep-injured dermal EPF-traced grafts at 7 dpw. 
Representative image of three biological replicates. i, j, Double matrix tracing 
in deep-injured fascia EPF-traced grafts at 14 dpw. Representative image of 
three biological replicates. k, l, Double matrix labelling in superficial-injured 
dermal EPF-traced grafts at 14 dpw immunolabelled for collagens. 
Representative image of three biological replicates. Dotted lines delimit the 
wound. Arrowheads mark the original injury. Continuous lines delimit  
the epidermis dermis margin. Scale bars, 500 μm (b), 100 μm (d–f) and 200 μm 
(h, j, l).
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Extended Data Fig. 7 | Fascia matrix forms the eschar and is remodelled in 
the wound. a, Left, in situ matrix tracing and collagen I, III and VI 
immunolabelling at defined time points after wounding. Representative 
images of three biological replicates. Right, subsampled fractal dimension 
maps of the FITC signal of uninjured tissue and at 3 and 7 dpw, and the collagen 
signal at 14 dpw. b, Matrix label coverage from total collagen I, III and VI signal in 
the wound. Data are mean ± s.e.m.; n = 3 (uninjured), 4 (3 dpw), 7 (7 dpw) and 4 
(14 dpw) sections analysed from 3 biological replicates. One-way ANOVA, 
Tukey’s multiple comparisons. c, d, Average fractal dimension (c) and 
lacunarity (d) from subsampled maps. Data are mean ± s.e.m.; n = 5 (uninjured), 
5 (3 dpw), 8 (7 dpw) and 3 (14 dpw) images analysed from 3 biological replicates. 
One-way ANOVA, Tukey’s test, 95% CI. e, Scatter plot of average fractal 
dimension and lacunarity values. f, In situ matrix tracing and SELP 
immunolabelling at defined time points after wounding. Representative 
images of three biological replicates. The broken line separates dermis from 
fascia. Dotted lines indicate the wound. Scale bars, 200 μm.
Extended Data Fig. 8 | Inflammation resolution and coagulation stay 
unaffected during fascia blocking. a, Sham (left) or ePTFE-implanted (right) 
wounds at 7 (top) or 63 dpw (bottom) immunolabelled for collagen I, III and VI. 
Representative images of three biological replicates. b–i, Immunolabellings 
(left) and fractions (right) of immune cells (PTPRC+; b), neutrophils (LY6G+; c), 
T cells (CD3+; d), NK cells (NCR1+; e), B cells (CD19+; f), macrophages and 
monocytes (MOMA2+; g) and cells expressing the pro- and anti-inflammatory 
cytokines (IL12 (h) and IL4 (i)). Mean with SEM, n = 3 images analysed from 3 
biological replicates. Unpaired two-tailed t-test, 95% CI (b). One-way ANOVA, 
Tukey’s test, 95% CI (c-i). j, Activated platelets (SELP) in 7 dpw sham and ePTFE-
implanted wounds. Representative images of 3 biological replicates. k, Mean 
grey value of SELP signal. Data are mean ± s.e.m.; n = 3 images analysed from 3 
biological replicates. Two-tailed Student’s t-test, 95% CI. Dotted lines delimit 
the wound area. Scale bars, 200 μm (main images) and 100 μm (magnified 
insets).
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Extended Data Fig. 9 | EPFs steer matrix in vitro independently of 
proliferation. a, En1cre;R26iDTR biopsies at day 0 and 6 after short treatment with 
DT or vehicle, immunolabelled for collagen I, III and VI. Representative images 
of three replicates. b, Collagens density. Data are mean ± s.e.m.; n = 3 images 
analysed from 3 biological replicates. Two-way ANOVA, multiple comparison 
Tukey’s test, 95% CI. c, Cell density. Data are mean ± s.e.m.; n = 3 images 
analysed from 3 biological replicates. One-way ANOVA, multiple comparison 
Tukey’s test, 95% CI. d, e, Time-lapse images (d) and contraction rate (e) of 
En1cre;R26iDTR neonate fascia biopsy in culture treated with DT for 1 h. 
Representative samples from three replicates. Contraction values obtained 
from Supplementary Videos 4, 6. f, Fascia biopsies treated with etoposide and 
immunolabelled for MKI67. g, Fraction of MKI67+ cells. Data are mean ± s.e.m.; 
n = 3 images analysed from 3 biological replicates. One-way ANOVA, Dunnett’s 
multiple comparisons, 95% CI. h, i, Time-lapse images (h) and contraction rate 
(i) of neonate fascia biopsy in culture treated with 100 μM etoposide. 
Representative samples from three replicates. Contraction values obtained 
from Supplementary Videos 4, 7. j, Mean (± s.e.m.) matrix contraction velocity 
during the first 25 h of imaging; n = 25 values from Supplementary Video 7. Two-
tailed Student’s t-test, 95% CI. Lines show the distance between two tracked 
points in the SHG channel. Scale bars, 50 μm (f), 200 μm (a, h) and 500 μm (d).
Extended Data Fig. 10 | Fascia matrix steering precedes proliferation in vivo. 
a, In situ fascia matrix labelling and EdU pulses. b, EdU detection in sections at 
defined time points. c, Fraction of EdU+ cells in the wound from total EdU+ cells. 
Data are mean ± s.e.m.; n = 3 (uninjured), 4 (3 dpw), 6 (7 dpw) and 4 (14 dpw) 
images analysed from 3 biological replicates. One-way ANOVA, Tukey’s 
multiple comparisons. Arrows indicate EdU-positive nuclei. Arrowheads 
indicate the original injury site. Broken and dotted lines delimit fascia and 
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